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Imagine applying for a job, and as part of your application process, your
prospective employer asks for a photograph. You, as an eager candidate,
comply with the request and, unbeknownst to you, the employer runs your
picture through a software program that scans you for any common genetic
diseases and that estimates your longevity. Alas, your face indicates that you
may die young. No job for you.
Although this sounds like science fiction, we may not be that far offfrom
this scenario. In June 2014, scientists from Oxford reported that they have
developed a facial recognition program that uses ordinary family photos to
help diagnose rare genetic conditions. Part II of this Article describes the
potential applications of facial recognition technology in medicine that have
recently been explored, highlighting the recent software that may be used for
genetic screening. Part III delves into the heightened need for privacy when
dealing with genetic conditions and discusses an individual's right not to know
about their genetic predispositions. Part IV discusses the history of facial
recognition technology in the United States and how it has been monitored and
regulated. This Part concludes that the current and proposed regulatory
regime for facial recognition technology is not well suited for medical
applications of such technology. Part V examines whether health-related
legislation, such as the Health Insurance Portability and Accountability Act of
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1996 (HIPPA), the Genetic Information Nondiscrimination Act (GINA), the
Food, Drug, and Cosmetic Act (FDCA), or the American with Disabilities Act
(ADA), provides adequate privacy protection from software that uses facial
recognition to screen for diseases or health and concludes that they do not.
Finally, Part VI outlines what kinds of restrictions are needed on the use of this
technology to protect patient's privacy. Such restrictions could be located
within GINA or ADA or could be part of a comprehensive regulation on facial
recognition technology in general. Whichever form it takes, such protections
are needed to ensure that what could be a very helpful technology is not used to
discriminate against individuals or to reveal information to a person who may
not seek such knowledge.
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I. INTRODUCTION
Imagine applying for a job, and as part of your application process, your
prospective employer asks for your photograph. You, as an eager candidate,
comply with the request, and, unbeknownst to you, the employer runs your
picture through a software program that scans you for any common genetic
diseases and that estimates your longevity. Alas, your face indicates that you
may die young and have an increased likelihood of having Marfan's syndrome,
which is associated with fatal aortic aneurysms. Other candidates do not have
these risk factors, and you are denied the job.
Although this sounds like science fiction, we may not be that far off from
this scenario. In the summer of 2014, Oxford scientists reported that they have
developed a facial recognition program that uses ordinary family photos to help
diagnose rare genetic conditions.! Under current law, it may not be long before
such software is commercially available for general use, including use by
employers.
Part II of this Article describes this and other potential applications of
facial recognition technology in medicine that have recently been explored,
highlighting the recent software that may be used for genetic screening and
1. Chris Weller, Rare Genetic Disorders Could Be Diagnosed with Facial Recognition Computer
Software, MED. DAILY (June 24, 2014, 3:04 PM), http://www.medicaldaily.com/rare-genetic-disorders-
could-be-diagnosed-facial-recognition-computer-software-289688.
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predicting longevity. This Part also explores potential ways these applications
may be used. The next Part delves into the heightened need for privacy when
dealing with health status, especially genetic conditions, and discusses an
individual's right not to know about their genetic predispositions. Part IV
discusses the ways that facial recognition technology is being regulated in the
United States. This Part concludes that the current and proposed regulatory
regime for facial recognition technology is not well suited for medical
applications of such technology. Part V examines whether health-related
legislation, such as the Health Insurance Portability and Accountability Act of
1996 (HIPAA), the Genetic Information Nondiscrimination Act (GINA),' the
Food Drug and Cosmetic Act (FDCA), 4 or the Americans with Disabilities Act
(ADA),5 provides adequate privacy protection from software that uses facial
recognition to screen for diseases or health and concludes that they do not.
Finally, Part VI outlines what kinds of restrictions are needed on the use of this
technology to protect patients' privacy.
This Article does not argue that the development of facial recognition
technology for medical purposes should be curbed. Such use could be very
revolutionary and beneficial for certain patients. However, there needs to be a
restriction on the use of such technology so that the resulting information
cannot be used by others, such as employers, for discriminatory purposes.
Restrictions could be located within GINA or ADA regulations or could be part
of a comprehensive regulation on facial recognition technology in general.
Whichever form it takes, such protections are needed to ensure that what could
be a very helpful technology is not used to discriminate against individuals or
to reveal information to a person who may not seek such knowledge.
II. MEDICAL AND HEALTH APPLICATIONS OF FACIAL RECOGNITION
TECHNOLOGY
Facial recognition technology (FRT) refers to systems and computer
programs that analyze images for identification purposes.6 When one thinks of
2. 29 U.S.C. § 1181 (2012).
3. 42 U.S.C. § 2000ff (2012).
4. 21 U.S.C. § 301 (2012).
5. 42 U.S.C. § 12101.
6. Q&A on Face-Recognition, ACLU, https://www.aclu.org/technology-and-liberty/qa-face-
recognition (last visited Mar. 14, 2016). The programs utilize measurements of facial characteristics to
create a unique file called a "template." Id. The FRT software compares the template to stored images
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FRT, one usually thinks of it being used for security or surveillance purposes.
Currently, FRT is used mainly for verification or authentication, which matches
a face-print with an individual record to identify a person.7 This application is
very useful for law enforcement to identify suspects.8 Another common use is
for identifying an unknown person from an anonymous picture.9 Current
commercial uses of FRT include, but are not limited to, general surveillance,
police initiatives (such as predicting what a missing child may look like several
years later), business-targeted marketing efforts, and social media application. 10
Medical applications of FRT have not been commonly used but that may soon
change."
and formulates a score that estimates the similarities. Id.
7. Id.
8. See, e.g., Ben Sobel, Facial Recognition Technology Is Everywhere. It May Not Be Legal,
WASH. POST (June 11, 2015), https://www.washingtonpost.com/news/the-switch/wp/2015/06/11/facial-
recognition-technology-is-everywhere-it-may-not-be-legal/.
9. Q&A on Face-Recognition, supra note 6.
10. See generally Jonathan Shaw, FACEbook Confidential: The Privacy Implications ofFacebook's
Surreptitious and Exploitative Utilization ofFacial Recognition Technology, 31 TEMP. J. SCI. TECH. &
ENVTL. L. 149, 149-50 (2012).
There has been much discussion of the Facebook FRT fiasco. "FRT is a major contributor to the
spectre of an Orwellian society. Facebook uses it to identify 'friends' from uploaded photos, which are
permanently affixed in cyberspace and accessible to the government." Kimberly N. Brown, Anonymity,
Faceprints, and the Constitution, 21 GEO. MASON L. REv. 409, 409 (2014).
"Facebook's 'tag suggestion' function automatically retrieves the names of individuals in photos
uploaded by its one billion users at a rate of three hundred million a day." Id. at 431. "Using only Face-
book and commercially available FRT, researchers in 2012 were able to identify college students more
than 30 percent of the time, retrieving their names, photos, and other personal information from Face-
book-including the first five digits of social security numbers-with the privacy settings turned on."
Id. at 429.
A concern raised about social media, and Facebook in particular, is that although Facebook stat-
ed that the data stored is monitored, restricted, encrypted, and secured, its privacy policy still holds the
right to "access, preserve and share information when we have a good faith belief it is necessary to: de-
tect, prevent and address ... illegal activity" or "to protect ourselves, you and others." Id. Government
systems employing FRT have access to social networking sites and can use the data to identify people.
Id. at 431. It was further revealed that the NSA has a program that can directly access data through
companies such as Facebook "for purposes of obtaining search histories, email content, file transfers,
and live chats." Id. at 432.
11. John Lynn, A Biometrically Controlled Healthcare System, EMR, EHR & HIPPA (Sept. 6,
2013), http://www.emrandhipaa.com/tag/facial-recognition/. Lynn dreams about a future with an "ID-
free" doctor's office that could potentially recognize a patient's face and ensure his or her records were
readily available for the physician. Id.
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A. FRT and Genetic Conditions
In June 2014, researchers from Oxford reported that they had developed
computer software that uses facial feature recognition to look for similarities
from a bank of computer-based photos of facial structures that have similar
genetic conditions, such as Down syndrome. 12 At the time of the report, the
software correctly predicted a genetic disorder, on average, ninety-three percent
of the time."
The concept of using facial feature recognition to diagnose diseases is not
new because many rare disorders do not have an accompanying genetic test and
specialists rely on analysis of facial features to help in diagnosis.1 4 However,
doctors with the requisite skill set for such diagnoses are scarce. There are over
17,000 genetic disorders that have been diagnosed, of which about 700 can be
diagnosed with the assistance of abnormal facial characteristic recognition."
The program developed by the scientists at Oxford currently can help identify
ninety individual disorders, and the hope is that it will be used where specialists
are unavailable.' 6 The software is not currently used as a sole test for diagnosis
but is used for assisting pediatricians in the process.17  In the future, this
program could be used to identify those born with a detectable disorder,
allowing for the option of early treatment." According to the study, previous
work has established that thirty to forty percent of all rare genetic disorders
impact how the face forms in some way and thus should be detectable with the
assistance of facial recognition technology. 19
12. Id. The new computer software was developed by Christoffer Nelliker and Andrew Zisserman
of the University of Oxford, along with their colleagues. Id. It was designed to assist doctors in making
a preliminary diagnosis of rare diseases. Id.
13. Id.
14. See Marie Ellis, Rare Genetic Disorders Diagnosed by Computer Analysis of Photos, MED.
NEWS TODAY (June 24, 2014), http://www.medicalnewstoday.com/articles/278708.php.
15. Josh Clark, Does the Shape of My Face Show that I Have a Genetic Disorder?, How STUFF
WORKS, http://science.howstuffworks.com/life/genetic/dysmorphology.htm (last visited Feb. 17, 2016).
16. See Weller, supra note 1.
17. Id. According to Nelliker, "it's not sufficiently accurate to provide a rock-solid diagnosis, but it
helps narrow down the possibilities." Id.
18. Diagnose Rare Disorders Using Photos, DECCAN CHRON. (June 25, 2014),
http://www.deccanchronicle.com/140625/1ifestyle-health-and-wellbeing/article/diagnose-rare-disorders-
using-photos. Additionally, "[a] diagnosis of a rare genetic disorder can be a very important step" and
"can provide parents with some certainty and help with genetic counseling on risks for other children or
how likely a condition is to be passed on," according to lead researcher Nelliker. Id.
19. Brian Stallard, Face Recognition Software Diagnoses Rare Disorders, NATURE WORLD NEWS
(June 24, 2014, 4:05 PM), http://www.natureworldnews.com/articles/7746/20140624/new-face-
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B. FRTand Aging
Additionally, scientists are working on a program that analyzes a person's
future outlook based on the aging of her face.2 0 The technology involves using
of a computer to scan pictures of faces for signs of aging based on various
factors.2 1 Biodemographer Jay Olshansky, professor of computer science Karl
Ricanek,2 2 and other computer scientists created the program to analyze
photographs of faces.2 3 The group started a website24 that invites people to
submit a photo and biographical information, which will be analyzed for the
return of feedback on their aging-rate calculations and longevity prospects.2 5
The technology is more personalized than other current approaches to face-
aging analysis, by using different algorithms based on gender and ethnic
group.26
There are some practical concerns with such uses, such as the reliability of
the data.27 However, Olshansky is optimistic regarding the new technology,
stating that an individual's face is a window to her overall health.28 "The face
recognition-software-diagnoses-rare-disorders.htm.
20. Tara Bahrampour, Can Your Face Reveal How Long You'll Live? New Technology May Provide
the Answer, WASH. POST (July 2, 2014), http://www.washingtonpost.com/national/health-science/can-
your-face-reveal-how-long-youll-live-new-technology-may-provide-the-answer/2014/07/02/640bacb4-
f748-11e3-a606-946fd632f9f1_story.html. Aging has become a "boom topic" for many entities as peo-
ple in the United States continually live longer, and research into the number of healthy years involved
in the aging process has become a topic for many researching institutes. Id. For example, companies
such as Google and Human Longevity have launched new programs focusing on aging and age-related
diseases, and the National Institutes of Health have also recently started an initiative addressing aging
and longevity. Id.
21. See id. ("Factoring in the subject's race, gender, education level and smoking history-all known
to affect longevity prospects-it would analyze each section of cheek, eye, brow, mouth and jowl look-
ing for shading variations that signal lines, dark spots, drooping and other age-related changes that might
indicate how the person is doing compared with others of the same age and background.").
22. See id. (addressing Professor Ricanek's work on facial recognition technology for the National
Security Agency, the CIA, and the FBI).
23. Id.
24. FACE MY AGE, http://www.facemyage.com/ (last visited Mar. 1, 2016); see Bahrampour, supra
note 20 ("[The website] is expected to deliver increasingly more accurate assessments and predictions as
more people participate. The researchers are hoping for large numbers of people-at least 10,000 or
20,000, but preferably more-to submit photos.").
25. See Bahrampour, supra note 20.
26. See id. (detailing Professor Ricanek's examples that the skin of individuals with lighter complex-
ion tends to age more quickly and women's faces tend to age more quickly than men's).
27. See id. (discussing Olshansky's concession that even if face aging is found to correlate with lon-
gevity, there will be outliers who do not fit the general pattern).
28. See id.
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picks up a lot of risk factors for health, such as tobacco smoking (wrinkles
around the mouth); excessive alcohol consumption (larger nose); and excessive
exposure to the sun (early brown spots and wrinkling) as well as stress,"
according to Olshansky.29 The hope is that as individuals receive feedback on
their own age analysis, it will contribute to the adoption of individual good,
healthy habits, ultimately resulting in longer life spans."
These two examples are just the tip of the iceberg. FRT is advancing at a
breakneck pace, and more medical and health applications of FRT are
inevitable. In the next Part, I discuss how medical applications of FRT raise
different privacy and ethical concerns than FRT for security or commercial
purposes.
The Patient Protection and Affordable Care Act (ACA) in part amends the
Public Health Service Act3' in addressing wellness programs "intended to
encourage workplace health promotion and prevention as a means to reduce the
burden of chronic illness, improve health, and slow the growth of health care
costs."3 2 Wellness programs are defined by the Public Health Service Act as
programs intended to "promote health or prevent disease."3 3 Under the ACA,
various types of programs available through employer-based group health plans
must meet certain requirements, and these programs vary from benefits
promoting healthy lifestyles to disease management.3 4 Specifically, the ACA
addresses the ability of employers to reward employee participation in group
health-plan wellness programs, which require employees to meet certain health
goals.
Section 27050) of the Public Health Service Act, as amended by the ACA,
increases the acceptable value of wellness incentives and gives discretion to
29. Id.
30. See id.
31. Office of the Assistant Sec'y for Planning and Evaluation, Report to Congress on Workplace
Wellness, U.S. DEP'T HEALTH & HUM. SERVICES [hereinafter Office of the Assistant Sec'y],
http://aspe.hhs.gov/hsp/13/WorkplaceWellness/rptwellness.cfm (last visited Feb. 24, 2016). The ACA
specifically amended the definition of a "wellness program" in section 2705(j)(1)(A) of the Public
Health Service Act.
32. Id.
33. 42 U.S.C. § 300gg-4(j)(1)(a) (2012); Office of the Assistant Sec'y, supra note 31.
34. Office of the Assistant Sec'y, supra note 31 ("[T]here is a wide array of workplace wellness pro-
grams which include employment-based activities or employer-sponsored benefits aimed to promote
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various government departments to determine if further increases are
appropriate.3 6 The final rules regarding employment-based, group health-plan
wellness programs were published in May 2013.37 The rule increases the
permissible rewards for "health-contingent wellness program[s]" from twenty
to thirty percent of the cost of coverage, as well as permitting a maximum
reward of fifty percent for programs that target tobacco cessation. 38 This rule
also sought to clarify the consumer protections that are required for these
wellness programs.39
Also applicable in employment-based wellness programming is section
2713 of the Public Health Service Act, which addresses preventive services
covered without cost-sharing. 40 This section "requires non-grandfathered group
health plans to cover a series of recommended preventive services without
imposing cost-sharing, including diet counseling for adults at a higher risk for
chronic disease, cholesterol screening for adults of certain ages or at a higher
risk, and blood pressure screening," including recommendations for tobacco
cessation programming.41
C. Implementation of Wellness Programs
Ordinarily, wellness programs include educating about health-related
issues, encouraging healthy lifestyle maintenance, and promoting healthier
choices.4 2  Typical programs include health-risk assessments, behavior
modification programs, and lifestyle education programs. 43  Some research
indicates that employee participation in wellness programming decreases the
36. 42 U.S.C. § 300gg-4; see Office of the Assistant Sec'y, supra note 31 ("[This section] raises the
allowable value of wellness incentives provided through employment-based group health coverage that
require satisfaction of a health-related standard from 20 percent to 30 percent of the cost of coverage in
2014 and provides discretion to the secretaries of DOL, HHS, and the Treasury to increase the reward to
up to 50 percent of the cost of coverage if they determine that such an increase is appropriate. It also
codifies in statute the HIPAA regulatory standards for health contingent wellness programs.").
37. Office of the Assistant Sec'y, supra note 31.
38. Id.; see 45 C.F.R. § 146.121(f) (2015).
39. Office of the Assistant Sec'y, supra note 31.
40. Id.; 29 C.F.R. § 2590.715-2713 (2015).
41. See 29 C.F.R. § 2590.715-2713; Office of the Assistant Sec'y, supra note 31.
42. Laura Anderko et al., Promoting Prevention Through the Affordable Care Act: Workplace Well-
ness, CENTERS DISEASE CONTROL (Dec. 13, 2012), http://www.cdc.gov/pcd/issues/2012/12_0092.htm.
43. Julia James, Workplace Wellness Programs, HEALTH POL'Y BRIEFS (May 16, 2013),
http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief id=81.
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cost of healthcare.4 These wellness programs must comply with various state
and federal laws, including the ADA, GINA, and HIPAA. 45  However, the
ACA regulations regarding wellness programs specifically state that the
regulations do not address the application of different laws to wellness
programs.4 6
Final ACA regulations separate wellness programming into two categories:
(1) "participatory wellness programs" and (2) "health-contingent wellness
programs." 47  Participatory wellness programs are "defined under the final
regulations as programs that either do not provide a reward or do not include
any conditions for obtaining a reward that are based on an individual satisfying
a standard that is related to a health factor."48  Health-contingent wellness
programs, in contrast, "require an individual to satisfy a standard related to a
health factor to obtain a reward (or require an individual to undertake more than
a similarly situated individual based on a health factor in order to obtain the
same reward)." 4 9 This may be performing an activity relating to a health factor
or reaching a specific outcome relating to one's health.so
Health-contingent programs are divided into two categories: (1) "activity-
only wellness programs" and (2) "outcome-based wellness programs."51 Under
an activity-only program, an employee is only required to complete the activity
involved, and it does not require the attainment of a specific health outcome. 52
44. See id. ("A review of thirty-six peer-reviewed studies of wellness programs in large firms found
that average employer medical costs fell $3.27 for every dollar spent on wellness programs, and costs
for days that employees were absent fell an average of $2.73. Similarly, a 2005 meta-analysis of fifty-
six published studies of health promotion programs at organizations of all sizes resulted in an overall
reduction of about 25 percent in sick leave, health plan costs, and workers compensation and disability
costs.").
45. Id.
46. Incentives for Nondiscriminatory Wellness Programs in Group Health Plans, 78 Fed. Reg.
33,158, 33,158 (June 3, 2013) (to be codified at 45 C.F.R. pt. 146-47).
47. Id.
48. Id. at 33,160. Examples include:
(1) A program that reimburses employees for all or part of the cost of membership in a fitness
center; (2) a diagnostic testing program that provides a reward for participation and does not
base any part of the reward on outcomes; and (3) a program that provides a reward to em-
ployees for attending a monthly, no-cost health education seminar.
Id. at 33,160-61.
49. Id. at 33,161.
50. Id.
5 1. Id.
52. Id. ("Examples of activity-only wellness programs include walking, diet, or exercise pro-
grams.").
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With an outcome-based program, "an individual must attain or maintain a
specific health outcome (such as not smoking or attaining certain results on
biometric screenings) in order to obtain a reward." 3 The health-contingent
programs are acceptable under the ACA if they meet five requirements: (1)
eligible individuals have the opportunity to qualify for the reward at least once
per year; (2) the total amount of the reward for all activity-only and outcome-
based wellness programs combined does not exceed the approved percentages;
(3) the program is reasonably designed to promote health or prevent disease;
(4) the full reward under both activity-only or outcome-based programs is
available to all similarly situated participants; and (5) the plan discloses the
availability of a reasonable alternative standard or program for individuals in all
plan health-contingent program materials.5 4
D. Concerns About Health-Contingent Wellness Programs
Although supported in the workplace by both employers and employees,
there is a conflict regarding the health-based incentive programming that
connects rewards to the achievement of a certain health status." One concern
voiced by organizations such as the American Heart Association is that this
approach may just shift healthcare costs from the healthy to the sick and that
the incentives are unfair because not all factors that contribute to a person's
health status are under an individual's control. 6 An example of this is genetic
predisposition, which can affect numerous different health-status factors, such
as excess weight or high blood pressure." Privacy concerns and the
discriminatory impact these types of programs could have on the low-income
population or racial and ethnic minorities are another concern." Finally, there
53. Id.
54. Id.
55. James, supra note 43.
56. Id.
57. Id. ("These arguments are some of the reasons the newly proposed federal regulations would
require that health-contingent wellness programs must not be overly burdensome on employees, and
must also offer a different, reasonable means of qualifying to any person who does not meet the standard
based on measurement, testing, or screening.").
58. Id. ("These people are more likely to have the health conditions that wellness programs target
and also may face more difficult barriers to healthy living. These barriers may include some that are
work related, such as having higher levels of job stress; job insecurity; and work scheduling issues. Bar-
riers outside of work may include personal issues, such as financial burdens, and environmental factors,
such as unsafe neighborhoods, poor public transportation, and lack of access to healthy food.").
1027
[Vol. 43: 1017, 2016] Balancing Privacy with Innovation
PEPPERDINE LAW REVIEW
have been concerns raised that the wellness program requirements may actually
discourage employee participation because participation may become
unaffordable."9
Further, there is "ambiguity and inconsistency" between the ACA and the
ADA. 60 The question posited is whether "a plan that varies premiums by 30
percent [is] truly voluntary? Might such a plan violate the ADA, even if it was
authorized by the ACA?"61 An example of this concern is found in a current
lawsuit filed by the EEOC on behalf of an employee who was allegedly fired
for refusal to participate in a health assessment.62  Normally, employees are
given incentives to participate in such programs, but in this case it is alleged
that failure to participate in the assessment would result in the employer no
longer covering any insurance premiums. 63 The EEOC's suit on behalf of the
employee states that requiring participation in the assessment and then firing
the employee for refusing to participate violated the ADA.64  The ADA
prohibits discrimination against the disabled, which includes "subjecting
workers to 'medical examinations and inquiries."'65 However, not all "medical
examinations and inquiries" are banned under the ADA, and voluntary health
assessments are usually allowed. But in this case, the voluntariness was
questioned because there was a lack of meaningful choice for participation in
this particular wellness program.
E. New Areas Addressed in the Context ofFRT
The Centre for Machine Vision68 is a company seeking to evolve human-
59. Id.
60. Anthony Brino, Do ACA Wellness Programs Violate Other Federal Laws?, Gov'T HEALTH IT
(Oct. 30, 2014), http://www.govhealthit.com/news/do-aca-wellness-programs-violate-other-federal-laws.
6 1. Id.
62. Nicholas Bagley, When Are Wellness Programs Illegal?, INCIDENTAL ECONOMIST (Aug. 22,
2014, 9:25 AM) (citing EEOC Lawsuit Challenges Orion Energy Wellness Program and Related Firing








68. BRL Centre for Machine Vision (CMV), U. W. ENG., http://wwwl.uwe.ac.uk/et/mvl (last visited
Mar. 15, 2016). CMV (formerly Machine Vision Laboratory) is part of the Bristol Robotics Laboratory
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computer interaction technology to new contexts. 69 The Centre has developed
use of "machine vision" to measure skin cancer growth, detect concealed
weapons, and identify changes in human emotions.70 The Centre has started to
work on a new project that uses facial recognition technology to identify
changes in mood, which would hypothetically allow measurement of certain
facial characteristics that may be able to identify people suffering from
depression because they are thought to display different facial characteristics. 71
"This could also have major benefits on caring for the elderly or ill in their
homes."72
Listed on the website as "coming soon," 73 WanderlD is an application of
facial recognition technology by Tactical Information Systems (TIS) 74 that will
be an identification system for at-risk individuals.7 ' The smart phone app will
allow caregivers to upload a picture to TIS, who will put it into a secure
database to be accessible by law enforcement and first responders.76 "When
first responders find an unidentified individual, they can take a photo using
their smartphone, upload it to WanderlD cloud servers, and the TIS database
can match the facial characteristics within minutes-with upwards of 99
percent accuracy."7 7 Thus, biometrics such as facial recognition may be able
"to help rescuers identify lost and confused people who have wandered away
from nursing homes or group care facilities" with this new technology.78
(BRL), a major research collaboration between the University of the West of England and the University
of Bristol. Id.
69. 4D Vision - Enabling Computers to Detect Human Emotions, U. W. ENG., http://wwwl.uwe.ac.




73. See WANDER ID, http://wanderid.com/ (last visited Feb. 25, 2016).
74. TACTICAL INFO. SYSTEMS, http://www.tacticalinfosys.com/index.html (last visited Feb. 25,
2016).
75. Kevin Benz, Biometric Matching in the Cloud: Tactical Information Systems Can Find You,




78. Heather Fraser, Can Wellness Devices Really Improve Health?, HEALTHCARE GLOBAL (Aug. 31,
2011), http://www.healthcareglobal.com/techll 195/Can-wellness-devices-really-improve-health.
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III. ETHICAL AND POLICY CONCERNS RELATED TO THE MEDICAL AND HEALTH
APPLICATIONS OF FACIAL RECOGNITION TECHNOLOGY
Healthcare is one the most highly regulated industries. 79 There are many
reasons for this. But one of the reasons is that health information is private, and
the government wants to ensure that it is not used in a way that is contrary to
public policy.so Genetic health information is subject to even more scrutiny
than other health information, due to the highly personal nature of such
information. When FRT begins delving into the healthcare and medical arena,
there is potential for good"' but also potential for misuse. This Part focuses on
the specific privacy concerns in the medical use of FRT: (1) use of this
information by employers or others in positions of power and (2) unique
privacy concerns with genetic diseases.
A. FRT and Aging: Ethical and Policy Concerns
Although the FRT research introduced above is new, one can easily
imagine how this technology could be used for good or nefarious purposes.
With regards to the FRT and aging software, on the positive side, individuals
who are not aging "well" may give up smoking or start exercising to slow their
aging process.82 However, employers could use these programs in employee
wellness programs, and life, disability, and long-term care insurance companies
could potentially use this technology in determining premiums. Also, as the
opening hypothetical intimates: "If at age 40 if there were something about
your face saying you're not likely to make it past 60, an employer could say,
'Oh, I'm not willing to promote you to some position of importance because
it's not likely to be a good investment."'83 After the advent of the Affordable
Care Act, insurance companies can no longer discriminate based on pre-
existing conditions, but it is not clear that "aging badly" would qualify as a pre-
79. An Unhealthy Burden, THE ECONOMIST (June 28, 2007), http://www.economist.com/node/94077
16.
80. See Health Insurance Portability and Accountability Act of 1996, 29 U.S.C. § 1181 (2012); see
also Your Rights Under HIPAA, U.S. DEP'T HEALTH & HuM. SERVICES, http://www.hhs.gov/hipaa/for-
individuals/guidance-materials-for-consumers/index.html (last visited Mar. 15, 2016).
81. Adam Rubenfire, Innovations: Facial Recognition Software Measures Pain, MOD. HEALTHCARE
(June 27, 2015), http://www.modernhealthcare.com/article/20150627/MAGAZINE/306279948.
82. Fraser, supra note 78.
83. Id.
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existing condition.84 Although these are concerns, the use of FRT in genetic
screening brings up a myriad of complex issues.
As FRT further develops, it could become commonly used for health and
insurance purposes." Although ERISA prevents individual underwriting to
determine premiums in employer-based plans, this information could still be
used in employer wellness programs and for life insurance, disability insurance,
and long-term care insurance policies. 6  Although the accuracy of this
technology will not be known for some time, ethical concerns about FRT in the
medical and insurance context are being raised now.8 7
B. FRT and Genetic Diagnosis: Ethical and Policy Concerns
The FRT software that can genetically screen faces has the potential for
good. With the use of this new program, a disease may be diagnosed earlier
and parents may be able to treat diseases and decide whether or not they will
have more children based on this information." Additionally, adults who are
exhibiting certain symptoms that cannot be explained may be able to receive
information from the differential diagnosis that helps tailor their case.
However, many carriers of genetic conditions are asymptomatic.8 9 In these
cases, there may not be a benefit to the knowledge gained by the FRT software.
The right not to know one's genetic disposition is a controversial issue. 90
84. See The 80/20 Rule and Other Health Care Cost Measures, UPMC (Oct. 28, 2014),
http://www.yourhealthcaresimplified.org/news/80-20-rule-other-health-care-cost-measures/.
85. Liz Klimas, Why Insurance Companies Are Interested in Facial Recognition Technology, THE




88. When this software is ready for widespread use, it should be accompanied by genetic counseling.
Karen Heller, Genetic Counseling: DNA Testing for the Patient, NAT'L CTR. FOR BIOTECHNOLOGY
INFO. (Apr. 2005), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1200714/. Although such counseling
gives individuals important understanding about medical implications, it does not come without reper-
cussions. Id. Genetic testing is foreboding to some, resulting in anxiety and guilt. Id. Also, family dy-
namics can be affected and can result in strained relationships. Id. Additionally, there is concern that
even with genetic counseling and subsequent testing, there is still misunderstanding and misinterpreta-
tion of the results. Id.
89. For example, persons who are only carriers of cystic fibrosis do not experience symptoms. See
Carrier Testing for CF, CYSTIC FIBROSIS FOUND., https://www.cff.org/What-is-CF/Testing/Carrier-
Testing-for-CF/ (last visited on Feb. 25, 2016).
90. Graeme Laurie, Recognizing the Right Not to Know: Conceptual, Professional, and Legal Impli-
cations, 42 J.L. MED. & ETHICS 53, 53 (2014).
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The concern is about whether and how genetic information is communicated to
individuals and what possible detrimental effects such information can have on
individuals. 91 These debates are often centered on the question of whether
individuals have a right to know or a right not to know their genetic
information. 9 2 Some people prefer not to know information about their genetic
predispositions or diseases and learning about such information could actually
cause them harm.93 For example, it is possible in some situations that an
individual could maintain better control over his life by not having the
information than by having it. 94  "The more information that might be
generated about the individual-due to progress in genetics and proteomics or
the expansion of health registers, for instance-the more important it may seem
to grant the individual means to avoid it in order to respect autonomy and
minimize potential harm."95
If the FRT is used on babies and children, there is a real policy issue about
these minors having a right not to know.96  Genetic testing on minors is only
91. Clarissa Allen, Karine S6n6cal & Denise Avard, Defining the Scope of Public Engagement: Ex-
amining the "Right Not to Know" in Public Health Genomics, 42 J.L. MED. & Emics 11, 11 (2014).
92. Gert Helgesson, Autonomy, the Right Not to Know, and the Right to Know Personal Research
Results: What Rights Are There, and Who Should Decide About Exceptions?, 42 J.L. MED. & ETHICS 28,
29 (2014).
93. W. Peter Guarnieri, Prince Harry and the Honey Trap: An Argument for Criminalizing the Non-
consensual Use of Genetic Information, 48 AM. CRIM. L. REV. 1789, 1792 (2011). This is particularly
the case in situations of incidental findings, when a physician finds something unexpected. Meredith
Salisbury, Should You Have the Right Not to Know Genetic Information?, FORBES (Nov. 5, 2013),
http://www.forbes.com/sites/techonomy/2013/11/05/should-you-have-the-right-not-to-know-genetic-
information/. If one applies for a job and then the FRT reveals a genetic pre-condition, this could be
seen as an incidental finding. See id. There is an issue regarding whether a person affected wants to
know the additional information and whether he should have the right to know (or not know) the results.
Id. Some advocates say that the correct answer is to only disclose the requested results, while others say
there is a duty to disclose all results. Id. In 2013, this debate rose to a higher level when the American
College of Medical Genetics and Genomics (ACMG) announced that this information was to be dis-
closed to patients who expressly rejected disclosure. Id. However, since then, the ACMG has changed
its recommendations. Id.
94. See Helgesson, supra note 92, at 33.
95. See id. at 30. In addition to the potential harm to individuals, there are also concerns for family
members who share the same DNA. Gabrielle Kohlmeier, The Risky Business ofLifestyle Genetic Test-
ing: Protecting Against Harmful Disclosure of Genetic Information, 2007 UCLA J.L. & TECH. 5, 24
(2007). Disclosure could result in anxiety, strained familial relationships, and stigmatization. Id. There
is also a potential "ripple effect" of genetic diseases, and thus, information within family members, in-
cluding partners and spouses of family members, can result in implications in reproduction. Laurie, su-
pra note 90, at 55.
96. See Pascal Borry, Mahsa Shabani & Heidi Carmen Howard, Is There a Right Time to Know?
The Right Not to Know and Genetic Testing in Children, 42 J.L. MED. & ETHICS 19, 20 (2014).
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advised when "established, effective, and important medical treatment" exists
or when testing "provides scope for treatment which to any essential degree
prevents, defers or alleviates the outbreak of disease or the consequences of the
outbreak of disease." 97 This principle should apply in the case of FRT as well.
If FRT reveals a high likelihood of an incurable disease for which there is no
treatment, it is easy to argue that perhaps the child is better off without
knowledge of the disease. Once they are adults, they can make their own
informed choice regarding such testing.98
"Incidental findings-traditionally defined as results that arise that are
outside the original purpose for which the test or procedure was conducted-
can create a range of practical, legal, and ethical challenges for recipients and
practitioners."99 An incidental discovery can be lifesaving in some contexts,
but in others it "can lead to uncertainty and distress without any corresponding
improvement in health or wellbeing." 00 Patients may also vary greatly in their
beliefs. Additionally, there are no current federal or state statutes that directly
address the duty to disclose incidental findings, recognizing that the context in
which this has been very briefly addressed is medical malpracticelo' and stating
that the legal standard of care may be implicated regarding incidental
findings. 102 In the research context, the Commission again noted that no federal
law or regulation or any state law specifically addressed disclosure of incidental
findings but also recognized that certain federal regulations could be applicable
if the context of disclosure was further defined.' Finally, in the direct-to-
97. Id.
98. Id.
99. PRESIDENTIAL COMM'N FOR THE STUDY OF BIOETHICAL ISSUES, ANTICIPATE AND
COMMUNICATE: ETHICAL MANAGEMENT OF INCIDENTAL AND SECONDARY FINDINGS IN THE CLINICAL,
RESEARCH, AND DIRECT-TO-CONSUMER CONTEXTS 22 (2013) [hereinafter ANTICIPATE AND
COMMUNICATE], http://bioethics.gov/sites/default/files/FINALAnticipateCommunicatePCSBIO.pdf.
100. Id. at 2.
101. Id. at 57-58 ("To date, few reported U.S. medical malpractice cases (as opposed to those settled
out of court) have addressed clinician liability for failure to identify or disclose incidental findings. A
recent study evaluating this limited body of case law concluded that it is possible that clinicians could
face liability for failure to identify or appreciate the significance of an incidental finding, or failure to
disclose an incidental finding to the patient or other clinicians, if recognition and disclosure would have
prevented or altered the course of future disease. In the 2006 case of Riley v. Stone, however, a Rhode
Island court found that the defendant neurologist did not breach the standard of care when he failed to
further assess an incidental finding that he deemed not to pose a danger to the patient." (citations omit-
ted)).
102. Id. at 58.
103. Id. at 81-82. This report first discusses The Common Rule, formally titled the "Federal Policy
for the Protection of Human Subjects," which is a set of regulations governing research with humans
1033
[Vol. 43: 1017, 2016] Balancing Privacy with Innovation
PEPPERDINE LAW REVIEW
consumer context, the Commission acknowledged that although there are some
state laws that regulate or prohibit direct-to-consumer services, there is no such
law directly regulating the disclosure of incidental findings.1 04 Further, in a
federal regulation context, the Food and Drug Administration (FDA) is
responsible for ensuring the safety of approved medical devices, but it typically
has no authority to regulate their use.'0o
1. Autonomy
Some argue that the choice of not knowing information about oneself is
"an expression of the own choices of an individual, which could be framed as a
right to informational self-determination.,1 0 6 Under the theory of autonomy,
the decision to know or not know information lies with the patient, not with the
physician.1 07  Patient autonomy allows the rejection of "paternalistic
interventions bordering on plain oppression for the sake of the overall good."' 8
Thus, if the genetic FRT software is used as a routine matter in certain doctors'
or employers' offices in the future and a genetic predisposition is revealed by
the person's face, does the healthcare provider or employer need to inform the
individual? If an adult individual does not want to know, that decision should
be respected.' 09
2. Privacy
Related to autonomy, the theory of privacy related to the decision not to
that establishes ethical protections. Id. at 81. Specifically, in the informed consent process:
[T]he Common Rule could require disclosure about the possibility of such findings and any
policy for their return. The Common Rule could also require disclosure of particular inci-
dental or secondary findings as "significant new findings developed during the course of the
research which may relate to the subject's willingness to continue participation."
Id. (citations omitted). Second, the report addresses HIPAA and individuals' rights to receive individual
medical information upon request, which could be implicated. Id. The report also addresses CLIA, a set
of federally mandated standards for lab testing of humans, over which there is currently disagreement
about whether incidental findings can be given to participants. Id. at 81-82.
104. Id. at 98.
105. Id. at 98-99.
106. Borry et al., supra note 96, at 21.
107. Id.
108. Helgesson, supra note 92, at 30.
109. See id.
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know rests on the concept of "control." 1 o Privacy advocates worry about
"unsolicited revelations of personal information" and recognize that such
actions may result in an invasion of privacy.11' The theory of privacy addresses
a broader spectrum of issues than autonomy, including the security of health
information and addressing situations such as the trust relationship established
between patients and doctors or participants and researchers." 2
3. International Guidance
The "right not to know"1 3 has been recognized by UNESCO in its 1997
Universal Declaration on the Human Genome and Human Rights, which states
in Article 5(c): "The right of each individual to decide whether or not to be
informed of the results of genetic examination and the resulting consequences
should be respected."1 4 The 1997 Council of Europe Oviedo Convention on
Human Rights and Biomedicine provided that "[e]veryone is entitled to know
any information collected about his or her health. However, the wishes of
individuals not to be so informed shall be observed."" 5
110. Borry et al., supra note 96, at 21-22.
111. Id. (quoting ALLEN E. BUCHANAN & DAN W. BROCK, DECIDING FOR OTHERS: THE ETHICS OF
SURROGATE DECISION MAKING (1989)).
112. See Laurie, supra note 90, at 61 ("[I]f participants cannot always negotiate and defend their own
interests, then they must trust that others do this on their behalf. Recognizing the possibility of the inter-
est in not knowing adds an important and powerful dimension to the trust relationship.").
113. Borry et al., supra note 96, at 20.
114. UNESCO, RECORDS OF THE GENERAL CONFERENCE: TWENTY-NINTH SESSION: RESOLUTIONS
41 (1997), http://unesdoc.unesco.org/images/001 1/001102/110220e.pdf; see Borry et al., supra note 96,
at 20; Laurie, supra note 90, at 53.
115. COUNCIL OF EUROPE, CONVENTION FOR THE PROTECTION OF HUMAN RIGHTS AND DIGNITY OF
THE HUMAN BEING WITH REGARD TO THE APPLICATION OF BIOLOGY AND MEDICINE: CONVENTION ON
HUMAN RIGHTS AND BIOMEDICINE 3 (1997); see Borry et al., supra note 96, at 20; Laurie, supra note
90, at 53. An additional example is the Dutch Civil Code, which states: "[I]f the patient indicates that he
does not want to receive information, then this is not provided, unless the potential resulting prejudice to
himself or others outweighs the patient's interest in not knowing." Charles E. Maclean, Creating a
Wanted Poster from a Drop of Blood: Using DNA Phenotyping to Generate an Artist's Rendering of an
Offender Based Only on DNA Shed at the Crime Scene, 36 HAMLINE L. REV. 357, 382 (2013) (citations
omitted). Further, the right not to know has been recognized in the context of minors by the British So-
ciety for Human Genetics guidelines by advising that "testing should normally be delayed until the
young person can decide for him/herself when, or whether, to be tested." See Borry et al., supra note 96,
at 21.
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IV. REGULATION OF FACIAL RECOGNITION TECHNOLOGY: FTC AND INDUSTRY
GUIDANCE
The Federal Trade Commission (FTC) released a comprehensive report in
2012 entitled Facing Facts, Best Practices for Common Uses of Facial
Recognition Technologies, which considered the beneficial uses to consumers
of FRT and the privacy issues that need to be researched with the expansion of
the commercial use of such technology." 6 The FTC recognized that the FRT
industry will continue to expand, discussed how the technologies are being
used, examined foreseeable future uses, and advised about the possible risks
and benefits of the technology.11 7  What is interesting is that none of the
described commercial uses involved medical or health applications. However,
the Report is still instructive for FRT for medical and health purposes.
The Report identified best practices for the commercial use of FRT:
privacy by design, simplified consumer choice, and transparency."' Numerous
professional groups participated in the Face Facts workshop, during which
discussion arose on the major topics involved in facial recognition technology:
"(1) recent advances in [the] technolog[y], (2) current commercial uses... , (3)
possible future uses . . . , and (4) privacy concerns."" 9
A. Recent Advances in FRT
In the Report, the FTC acknowledged that the commercial use of FRT is
becoming more prevalent due to lower costs and higher accuracy. 120
116. FED. TRADE COMM'N, FACING FACTS: BEST PRACTICES FOR COMMON USES OF FACIAL
RECOGNITION TECHNOLOGIES 1-2 (2012) [hereinafter FACING FACTS REPORT],
http://www.ftc.gov/sites/default/files/documents/reports/facing-facts-best-practices-common-uses-facial-
recognition-technologies/121022facialtechrpt.pdf. The Report stemmed from the FTC's Face Facts
workshop in December 2011, which initially discussed the uses of FRT and the impact on consumers.
Id. at 1. The workshop was followed by a period of public comment, which was used to help develop
the recommended best practices for the commercial use of the facial recognition technology. Id.
117. Id.
118. See id. at 1-2 (citing FED. TRADE COMM'N, PROTECTING CONSUMER PRIVACY IN AN ERA OF
RAPID CHANGE, RECOMMENDATIONS FOR BUSINESSES AND POLICYMAKERS (2012), http://www.fic.gov/
os/2012/03/120326privacyreport.pdf).
119. See id. at 3. "Researchers, academics, industry representatives, and consumer and privacy pro-
fessionals" were all a part of the workshop discussions. Id. The developments discussed were "technol-
ogies that merely detect basic human facial geometry; technologies that analyze facial geometry to pre-
dict demographic characteristics, expression, or emotions; and technologies that measure unique facial
biometrics." Id.
120. See id. at 3-4 ("For example, from 1993 to 2010, tests conducted by the National Institute of
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Previously, programs utilizing FRT were unlikely to match two images of the
same person "if the photos were taken from different angles."'21 However, the
Report describes how many companies use 3D images to solve this issue.1 22
Several of the technological advancements are attributed to the increase in
availability of online photographs.1 2 3  The Report cites Facebook as an
example, noting that consumers uploaded 2.5 billion photos in a single month
in 2010.124
B. Current Commercial Uses of FRT
The Report does not anticipate the commercial medical or health uses of
FRT. However, the Report is still instructive. It describes various current uses,
from general facial detection technologies1 25 to specific identification of an
individual person.1 2 6  The Report focuses on the current commercial uses of
facial detection, such as search engine results,1 2 7 virtual eyeglass fitting systems
and makeover tools,1 28 and real-time targeted advertising.1 29 Real-time targeted
Standards and Technology (NIST) showed that the false reject rate-the rate at which facial recognition
systems incorrectly rejected a match between two faces that are, in fact, the same-was reduced by half
every two years.").
121. Id. at 4.
122. See id.
123. See id. (noting that ten years ago, most online images were of celebrities, while increased social
media has led to a huge influx of images of private citizens online).
124. See id. ("This multitude of identified images online can eliminate the need to purchase proprie-
tary sets of identified images, thereby lowering costs and making facial recognition technologies com-
mercially viable for a broader spectrum of commercial entities."). Participants in the workshop also
mentioned several other developments that have also attributed to the increase accuracy of facial recog-
nition technology, including better digital cameras with higher quality images. Id. at 3.
125. See id. at 4. This is the ability to detect a face in an image. Id. Workshop participants also
looked at possible future uses of the technology, most of the conversation focusing on the possibility of
using facial recognition to identify anonymous people in public places. Id. at 6-7. Although it seems
currently impossible for commercial use on a large scale, the FTC referenced studies that suggest it may
be possible in the future. Id.
126. See id. at 4. Specific identification is when an image of a person "is matched with another image
of the same individual." Id. Thus, "if the face in either of the two images is identified ... then, in addi-
tion to demonstrating a match between two faces, the technology can be used to identify previously
anonymous faces." Id. The middle ground between these two types of technology also encompasses
determining facial characteristics that are attributed to "age, gender, and recognizing emotions." Id.
127. See id. at 5 ("[R]efining search engine results to include only those results that contain a face,
locating faces in images in order to blur or de-identify them, or ensuring that the frame for a video chat
feed actually includes a face.").
128. See id. A consumer uploads a "selfie" to the website, where basic facial features are used to su-
perimpose the product on the consumer's face. See id.
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advertising benefits advertisers because it expands their targeted audience and
could lead to more sales.130  The FTC discussed SceneTap as an example,
which uses FRT to capture age range and gender of clientele at bars and
nightclubs to determine demographics and could provide helpful information to
venue operators and third-party vendors to target their promotions.131
The Report also discussed how FRT is being used for authentication
purposes132 and on social network sites.133 The most widespread use of the
comparison and identification technology in FRT is to implement semi-
automatic "tagging" on social network sites in photo management and
applications. 34  The existing system is limited to suggestions of "'tags' of
people that the user already knows" or with whom they have a mutual
"friend." 35
C. Privacy Concerns Raised by the FTC Report
Although many of the examples cited by the FTC demonstrated consumer
benefits and even the ability of the commercial entity to protect privacy, the
Report documented many privacy concerns. 3 6  The concerns raised at the
workshop included that databases storing the sensitive information may be at
risk for hacking, consumers may view targeted facial recognition advertising as
an invasion of privacy, and the technology may eliminate the ability for
individual anonymity in public places. 3 7 The third concern delivered the most
concern to the participants of the workshop, stemming from "serious privacy
129. See id. ("For instance, technologies that identify moods or emotions from facial expressions can
be used to determine a player's engagement with a video game or a viewer's excitement during a movie.
Further, technologies that can determine the gender and age range of the person standing in front of a
camera can be placed into digital signs or kiosks, allowing advertisers to deliver an advertisement in
real-time based on the demographic of the viewer.").
130. Id.
131. See id. at 5-6 ("SceneTap also makes the aggregate information it collects available through a
mobile app that consumers can use to make decisions about which venues to patronize."). Although
these programs go beyond simply detecting a face in an image, they do not use the "biometric data for
comparison purposes." Id.
132. See id. at 6 ("For example, they can be used for authentication purposes by enabling a mobile




136. Id. at 7-8.
137. Id.
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and physical safety concerns." 38
The FTC requested public comments regarding issues raised on privacy
concerns and best practices for the commercial implementation of facial
recognition technology.1 39  The feedback provided encompassed several
underlying themes, including that: (1) "companies should implement privacy
protections for all facial recognition technologies"; (2) transparency is
necessary, which includes the need for consumer education, especially among
teens; and (3) the role of self-regulation and the implementation of industry
"best practice" standards. 14 0 The FTC, in agreeing with the commentary, noted
that most of the principles suggested were the same as those suggested in the
March 2012 FTC Privacy Report.1 41
Thus, the FTC developed case studies demonstrating how commercial
entities could implement the suggested principles when using facial recognition
technology.1 4 2 The studies were not intended to provide an exhaustive list of
138. Id. at 8. The overarching concern results in the consensus that before implementation of any of
the abovementioned technologies, there needs to be implementation of appropriate privacy protections.
Id. at 7-8.
139. Id. at 8; see FTC Seeks Public Comments on Facial Recognition Technology, FED. TRADE
CoMMIssioN (Dec. 23, 2011), https://www.ftc.gov/news-events/press-releases/2011/12/ftc-seeks-public-
comments-facial-recognition-technology.
140. FACING FACTS REPORT, supra note 116, at 9-10.
141. See id. at 10 ("[P]rivacy by design, simplified choice, and improved transparency.").
142. See id. at 10-20. There were three hypotheticals described by the FTC. In the first scenario, an
eyeglass company implements a website which allows consumers to upload their pictures and superim-
pose different styles of glasses on their face, storing the images for future use by the consumer. Id. at
11. According to the FTC, the voluntary photo upload is not the concern, it is the company's storage of
the image that raises the issue. Id. The best practices suggested by the FTC in this scenario first include
implementation of "privacy by design" by protecting the uploaded images. Id. at 11-12. Second, the
recommendation for implementation of transparency, the company should communicate its use of the
data and provide consumer choices in the context of the transaction. Id. at 12. An example given by the
FTC was to state, at the time of photo upload, information regarding the reasons for storing instead of
deleting the photos, etc., further stating, "In all cases, the company should also inform consumers of: (1)
the length of time the images are stored, (2) who will have access to the stored images, and (3) consum-
ers' rights regarding deletion of the stored images." Id. Third, the FTC recommended that if use of the
data changes, the company needs to obtain "affirmative express consent of the consumer." Id. As an
example, if the eyeglass company decided to use the image for advertising rather than just storing the
image for the consumer, it would require affirmative consent. Id.
In the second hypothetical, the FTC examines a sports drink company using digital signs in a
grocery store to display targeted advertisement to the consumer in front of the sign through assessing
age range and gender. Id. at 13. In this case, "[t]he consumer's image is processed instantaneously" and
is not kept for future use. Id. According to the FTC, "privacy by design" should be used to prevent in-
stantaneous system hacking by using data security protections. Id. Regarding company transparency,
the suggestion is that clear notice that the digital sign contains a camera using facial recognition tech-
nology is needed. Id. at 15. Consumer choice is also notably important in this hypothetical, clear notice
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implementation techniques, but rather to provide an example of suggested best
practices.1 4 3 Each of these best practices focused on privacy by design through
technological fixes, such as protecting uploading facial images, preventing
hacking, protecting user data, and appropriately establishing retention and
disposal practices.144 They also focused on implementation of transparency,
consumer choice, and consent.1 45 Each of these principles-privacy by design,
simplified choice, and improved transparency-can be applied to the FRT for
medical and health purposes. FRT for medical and health purposes must ensure
the technology is secure, that it is used with patient consent, and those patients
know every way that the results will be used. Although this would be better
than nothing, the FTC guidance is just that-guidance.
It is interesting that FTC Commissioner Rosch dissented with the issuance
of the report.1 46  Overall, he felt that the report by the FTC was premature
because he did not believe that "such far-reaching conclusions ... can be
justified at this time."147 Three years later, it seems that the FTC Report was
prescient and actually under anticipated some of the uses of FRT. If anything,
the new applications of FRT point to the need for even more stringent
is applicable so a consumer can choose to avoid the sign. Id. Again, if the company decides to use the
information in a way other than originally intended, such as collecting the data, the company needs to
first obtain affirmative, express consent of the consumer. Id. at 16.
The last hypothetical examines a social network that implements facial recognition, specifically
regarding user photo uploads, and the network scanning the photos against "tagged" photos of the user's
"friends." Id. at 17. This system would allow for the site to identify the user's "friends" in new photos
for the user to "tag." Id. "Privacy by design" is discussed in this scenario as highly important, including
the various ways to protect user data, and appropriately establishing retention and disposal practices. Id.
at 17-18. Transparency and consumer choice are also suggested, by informing the consumer about the
network's data practices, and letting the consumer choose whether to participate in the use of facial
recognition technology, further stating that consumers need to have the option to turn of the feature any-
time, thereby deleting the previously collected biometric data. Id. at 18-19. The final suggestion for the
social networks is that that it should not collect and store data of non-users because non-users have an
absence of choice regarding such practices. Id. at 19. Thus, this leads to the conclusion that these net-
works need to obtain express, affirmative consent from all of those who participate in the program, as
only consumers who have affirmatively chosen to participate should be identified. Id. at 20.
143. See id. at 10-20.
144. See generally id. (providing examples of best practices as applied to three case studies).
145. See id.
146. See id. at Al-A2 (Rosch, Comm'r, dissenting). Rosch disagreed that "best practices" should be
adopted by the FTC solely because the technology has a possibility for misuse, stating that it was "at
least premature . . . to suggest to businesses that they should adopt as 'best practices' safeguards that
may be costly and inefficient against misconduct that may never occur." Id. at A2. Rosch opposed the
"consumer choice" model implemented in the report, stating it is nearly impossible to establish an exact
"consumer[] expectations" test. Id.
147. Id.
1040
[Vol. 43: 1017, 2016] Balancing Privacy with Innovation
PEPPERDINE LAW REVIEW
standards. Companies are not required to abide by the recommendations-
compliance with the best practices is purely voluntary.1 48  The FTC outlines
best practices as a guide to company policy regarding facial recognition
technology.1 49 By utilizing the suggestions, companies can promote consumer
trust and ensure industry growth, thus incentivizing additional companies to
implement the suggested best practices.15 0
D. Industry Efforts at Self-Regulation
In addition to the FTC's proposed best practices, there have been some
limited industry efforts at self-regulation. Because FRT-based interactive
marketing will likely be used by the digital sign industry,'"' the Digital Signage
Federation (DSF) has set forth recommended industry standards based on the
privacy implications involved. 5 2 Although DSF deals with different aspects of
FRT than those related to medical and health practices, some of its analysis is
translatable.1 53 After examining current privacy protection implementation and
industry practices, the DSF noted that these generally extended to "personally
identifiable information"15 4 traditionally assumed to be the only information
that could be directly linked to a person's identity.5 5  However, the DSF noted
148. Id. at iii ("The recommended best practices contained in this report are intended to provide guid-
ance to commercial entities that are using or plan to use facial recognition technologies in their products
and services.").
149. Id. (noting that the recommended best practices "are not intended to serve as a template for law
enforcement actions or regulations").
150. Id. at 21.
151. See DIG. SIGNAGE FED'N, DIGITAL SIGNAGE PRIVACY STANDARDS 1 (2011), http://www.digital-
signagefederation.org/Resources/Documents/Articles%20and%20Whitepapers/DSF%20Digital%2Sig-
nage%20Privacy/o20Standards%2002-2011%20%283%29.pdf ("Through technologies and platforms
like mobile marketing, social networking, facial recognition and radio frequency identification, digital
signage companies can personalize message content, build customer relationships, streamline network
management and provide accountability to advertising clients.").
152. Id.
153. Accord id. (suggesting the recommendations are focused on "preserv[ing] public trust .... [and]
prevent[ing] privacy risks"). The goals and motivations at the heart of the Digital Signage Federation's
suggestions mirror those discussed in this article with regard to medical uses of FRT. Id.; see also supra
Part M.A.
154. See DIG. SIGNAGE FED'N, supra note 151, at 1-2. Also known as "directly identifiable data,"
typically including name, address, phone number, date of birth, social security number, driver's license
number, license plate number, email address, account numbers, or "biometric data, such as unique data
points captured via facial recognition systems [and] [i]mages or voice recordings of individuals." Id. at
2.
155. Id. at 1-2.
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that the distinction between information that is personally identifiable and
information that is not is becoming less meaningful as technology progresses.15 6
The DSF recommended that privacy protections also extend to "pseudonymous
data," 57 or data that does not directly identify an individual but can be traced to
a person's identity relatively easily. 15 This concept is important and should
extend to FRT for medical or health purposes as well.
The DSF proposed eight separate policy considerations to assist in
promoting privacy protection. These include transparency, 15 9 individual
participation,1 60 purpose specification, 16 1 data minimization,1 62 use limitation, 163
data quality and integrity 64 security,165 and accountability.' 66 The guidelines
set forth by the DSF are based on internationally recognized principles outlined
in the Fair Information Practices, which the DSF explains are incorporated both
in privacy laws in the United States and the European Union's Data Protection
Directive.1 6 7 In addition to recommending general guidelines, the DSF further
156. Id.
157. See id. at 2. This data includes RFID codes; device identification numbers, such as IP addresses;
internet usernames; social networking data; and data a user enters knowingly. Id. The report suggests
the need for protection over information so easily used to identify an individual. Id.
158. Id.
159. Id. at 4-6. This refers to the two principal ways of implementation: through development of
"concise and specific" privacy policies to be published on companies' websites and specific notice at the
location of the digital sign. Id.
160. See id. at 6-8. Individual participation refers to the individual's right to consent to the collection
and use of their data, and the right to access the collected data. Id at 6. The DSF examines the three
general ways information is collected-audience counting, audience targeting, and audience identifica-
tion and profiling-and how the system operates and how consent should be obtained in each scenario.
Id. at 6-8.
161. See id. at 8. This refers to the recommendation that companies disclose the intended use of the
data collected through privacy policies. Id.
162. Id. Data minimization refers to the collection and retention of data. Id. The DSF proposes that
companies collect "only the minimum amount they need to achieve specified ends," and that the data
collected should be kept no longer than necessary. Id.
163. Id. The DSF proposes that companies not use or share the collected data in a way that is not dis-
closed in the company's privacy policies. Id.
164. Id. at 9. The DSF suggests that data quality and integrity can be ensured through consumer ac-
cess and best practices. Id. The data should be "accurate, relevant, timely, and complete." Id.
165. The DSF identifies employee access, systems security, and database retention principles as key
aspects of a security policy. Id. ("The best data security is for a company not to possess consumer data
in the first place.").
166. Accountability refers to the fact that companies should implement internal systems to regulate
compliance with privacy policies and applicable laws, as well as provide training for employees. Id.
167. Id. at 4 (providing as an example the "modern formulation of these principles" adopted by the
U.S. Department of Homeland Security, including: transparency, individual participation, purpose speci-
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proposed that digital signage companies reach out to existing privacy
frameworks related to the utilized technologies for use in the development of
policies and best practices.168
E. CDT
The Center for Democracy and Technology (CDT) has considered the
privacy issues involved in FRT. 69 In its 2012 report, the CDT described the
privacy concerns in the context of three main levels.1 70 Level one is individual
counting, where consumer facial information is used as a general recognition
mechanism and gathered on an aggregate basis but not stored.' 7 ' The CDT
labels this level as the least likely form of FRT to intrude on individual
privacy.1 7 2  Level two is individual targeting, in which facial information is
used in making targeted advertisements. 7 1 In this system the information is not
retained, but is used, for example, to "record passerby demographics and
contextualize ads accordingly."1 74  Level three is called individual
identification, where the individual's data is collected and facial information is
linked to an individual's identity, property, or location. 7 5
The CDT argues that current state and federal regulations are not adequate
to protect consumers in the FRT arena; most state and federal laws do not
address consumer privacy protection of biometric information collected for
commercial purposes.1 7 6 Federal law does not explicitly address the use of FRT
fication, data minimization, use limitation, data quality and integrity, security, and accountability).
168. See id. ("[D]igital signage companies that utilize mobile marketing should use the Mobile Mar-
keting Association (MMA)'s Global Code of Conduct .... [C]ompanies that use RFID should integrate
the standards of relevant trade associations or privacy groups ... . [C]ompanies that target advertise-
ments to consumers based on their activities may want to consider the online behavioral advertising
guidelines issued by the Network Advertising Initiative and by the Interactive Advertising Bureau ...
[and] companies should be aware of other digital signage privacy guidelines, including the very well
done Code of Conduct issued by Point of Purchase Association International.").
169. CTR. FOR DEMOCRACY & TECH., SEEING IS ID'iNG: FACIAL RECOGNITION & PRIVACY 1 (2012),
https://www.cdt.org/files/pdfs/Facial Recognition and Privacy-
Center for DemocracyandTechnology-January_2012.pdf.






176. Id. at 9 ("Federal laws-and nearly all state laws-do not provide American consumers with
basic privacy protections when it comes to biometric information collected for commercial purposes
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in the private sector, although it does provide a legal remedy for the
unauthorized use of such information in the context of identity theft or fraud.1 77
The CDT suggests that legislative remedies could be introduced that would
help in this arena. The CDT believes it would be better if Congress "pass[ed] a
strong baseline consumer privacy law,""' rather than targeting FRT alone.' 7 9 It
suggests that privacy law in the United States is fragmented and "[e]stablishing
privacy laws for facial recognition in isolation will perpetuate this
fragmentation," leading to ineffective protection for consumers.so
F. National Telecommunications & Information Administration 2014
Meetings on FRT
FRT is a topic ripe for discussion because it is rapidly expanding in its
sophistication and use. The National Telecommunications & Information
Administration (NTIA) of the United States Department of Commerce is
another governmental body that is attempting to address FRT.'"' The NTIA
held a series of meetings in 2014 regarding the commercial use of FRT.18 2
NTIA intended for the meetings and feedback to lead to the development of an
online or offline.").
177. Id. (noting further "both the Privacy Act and Office of Management and Budget memoranda
cover biometric information held by government agencies.").
178. Id. at 13.
179. Id. A baseline law could help by "providing consumers with a measure of control over whether
they participate in commercial facial recognition systems and requiring companies to be transparent
about their use of facial recognition." Id. It "should also establish a safe harbor program in which com-
panies that adhere to enforceable industry self-regulatory privacy codes enjoy specified incentives, such
as exemption from some forms of liability." Id.
180. Id. at 13-14.
181. See Nat'l Telecomm. & Info. Admin., Privacy Multistakeholder Process: Facial Recognition
Technology, U.S. DEP'T COM. (June 11, 2015) [hereinafter Privacy Multistakeholder Process: Facial
Recognition Technology], http://www.ntia.doc.gov/other-publication/2014/privacy-multistakeholder-
process-facial-recognition-technology.
182. Id.; see also Lawrence E. Strickling, NTIA to Convene First Facial Recognition Technology
Mutlistakeholder Meeting, U.S. DEP'T COM. (Feb. 5, 2014), https://www.ntia.doc.gov/blog/2014/ntia-
convene-first-facial-recognition-technology-multistakeholder-meeting. The goal of the meetings was set
forth as involving a stakeholder discussion on best practices to "ensure that consumers' rights to control,
transparency, security, access and accuracy, focused collection, and accountability are respected within
the context of current and emerging commercial uses of facial recognition technology." Nat'l Tele-
comm. & Info. Admin., Privacy Multistakeholder Meetings Regarding Facial Recognition Technology:
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enforceable code of conduct specifying how the Consumer Privacy Bill of
Rights applies to the use of FRT.18 3  The NTIA acknowledged that FRT has
many potential benefits for consumers but also noted that there are serious
privacy challenges involved.1 84 The NTIA also used the FTC Report and other
academic publications in the stakeholder discussion process.' Unfortunately,
183. Privacy Multistakeholder Meetings, supra note 182. The February 25, 2014, meeting discussed
proposed cases to be used as examples of how the code of conduct could address the issues involved,
including use of facial recognition technology used through surveillance cameras, mobile applications,
and kiosks. NAT'L TELECOMM. & INFO. ADMIN., NTIA PRIVACY MULTISTAKEHOLDER PROCESS,
COMMERCIAL FACIAL RECOGNITION TECHNOLOGY, PROPOSED USE CASES THAT MIGHT BE ADDRESSED
BY A CODE OF CONDUCT 1 (Feb. 21, 2014), http://www.ntia.doc.gov/files/ntia/publications/stakeholder_
usecases_2_21_14.pdf. The subsequent meeting on March 25, 2014, provided a list of documentation
to be used as a background resources for the meetings, including the FTC documentation on best prac-
tices. NAT'L TELECOMM. & INFO. ADMIN., NTIA PRIVACY MULTISTAKEHOLDER PROCESS,
COMMERCIAL FACIAL RECOGNITION TECHNOLOGY, PRELIMINARY BACKGROUND RESOURCES 1 (2014),
http://www.ntia.doc.gov/files/ntia/publications/background resourcesfacial-recognition_3_24_14.pdf;
see FACING FACTS REPORT, supra note 116, at 4-6. The March 25th meeting also updated the proposed
use cases list to twenty-nine scenarios where a code of conduct could be implemented to address con-
cerns arising from the use of facial recognition technology. See also NAT'L TELECOMM. & INFO.
ADMIN., NTIA PRIVACY MULTISTAKEHOLDER PROCESS, COMMERCIAL FACIAL RECOGNITION
TECHNOLOGY, PROPOSED USE CASES THAT MIGHT HE ADDRESSED BY A CODE OF CONDUCT 1 (Mar. 24,
2014), http://www.ntia.doc.gov/files/ntia/publications/stakeholder usecases_3_24_14.pdf. Further,
this meeting included information provided by IBG, a company involved in independent biometric test-
ing. INT'L BIOMETRIC GRP., FACE PROCESSING IN SOCIAL NETWORKING SERVICES (2014),
http://www.ntia.doc.gov/files/ntia/publications/ntia325meetingfinaLpdf. The report was titled Face
Processing in Social Networking Services and addressed the background facts pertinent to face pro-
cessing technologies. Id. at 3-4. A subsequent conference call on March 26, 2014, provided infor-
mation on facial recognition in online and mobile services in the European Union. JACOB KOHNSTAMM,
EUROPEAN COMM'N, OPINION 02/2012 ON FACIAL RECOGNITION IN ONLINE AND MOBILE SERVICES
(2012), http://ec.europa.eu/justice/data-protection/article-29/documentation/opinion-recommendation/
files/2012/wpl92_en.pdf. The documentation provided addresses varying uses of facial recognition
technology, providing examples specifically in the online and mobile services realms. Id. at 1-2. The
report provides recommendations for the encountered risks, including: companies providing detailed
information, obtaining informed consent, using the data for specified purposes, allowing for consumer
access, and adequate security systems. Id. at 7-9. These proposals are contextualized by a discussion of
the European Union's legal framework, called the Data Protection Directive, which addresses digital
images as personal data and the processes involved, as well as providing recommendations for the en-
countered risks. Id. at 3-7.
184. Privacy Multistakeholder Meetings, supra note 182. The specific challenges involved include:
"(1) securing sensitive biometric data; (2) providing transparency when facial recognition is implement-
ed in retail stores or other public places; and (3) developing meaningful controls for consumers when the
source material for facial recognition technology-digital images-is often widely available." Id.
185. See id. ("These [FTC reports and academic publications] indicate that the facial recognition topic
is a strong opportunity for stakeholders to reach consensus on a code of conduct in a reasonable
timeframe."). The initial stakeholder meetings were set to start a "factual, stakeholder-driven dialogue"
regarding facial recognition technology, how it is currently implemented, how it may be used in the fu-
ture, and the privacy concerns involved. Id. Further meetings were scheduled with the intent to formu-
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the meetings to date have not addressed FRT use for medical or health
purposes; they have focused instead on concerns about the software security
and not about how the information garnered by the FRT is used. 186
All of the meetings have resulted in interesting conclusions, but the
conclusions made at the March 2014 meeting were instructive on privacy
issues. '87  The NTIA considered the issue of whether a biometric template
stored without other identifying information could still be considered a unique
identifier.'8 8  The participants at that meeting concluded "a face recognition
template is [personal identifying information], like any other biometric
information.""' This language is of particular interest because it lends
credence to the arguments I make in the HIPAA section below that FRT
implicates individually identifiable data.
The NTIA also considered whether breaking into the template, image
reconstruction, and template linking would "require a sophisticated attacker
with a Ph.D.?"'o Unfortunately, the answer was that an unsophisticated hacker
could do this because the algorithms have already been developed, and all that
is needed is the software.191 This is particularly worrisome in the case of FRT
for health or medical use because health information should be afforded the
utmost privacy.
At the May 2014 meeting, the stakeholders were more specific and
submitted a proposal for principles that may be incorporated into the code of
conduct.1 92 The ACLU submitted its report, entitled An Ethical Framework for
lize the code of conduct setting forth privacy practices for the industry. Id.
186. See Privacy Multistakeholder Process: Facial Recognition Technology (2015), NAT'L
TELECOMM. & INFO. ADMIN. (June 11, 2015), https://www.ntia.doc.gov/other-publication/2015/privacy-
multistakeholder-process-facial-recognition-technology (providing agendas, recommendations, and re-
lated documents for the meetings held in 2014).
187. MICHELLE CHIBBA & ALEX STOIANOV, INFO. & PRIVACY COMM'N OFFICE OF ONT., CAN., ON
UNIQUENESS OF FACIAL RECOGNITION TEMPLATES (2014), http://www.ntia.doc.gov/files/ntialpublic-
ations/uniqueness-of face recognitiontemplates-ipcmarch-2014.pdf.
188. Id. at 1-2.
189. Id. at 2. The NTIA also considered the question of whether a facial image can "be reconstructed
from the template especially if the template generating algorithm is not known. . . ." Id. According to
the experts at the meeting, approximately 93% of the time this can be done successfully in the system.
Id. at 3. The meeting also concluded that two facial templates created for the same person but by differ-
ent algorithms can be linked. Id. at 4.
190. CHIBBA & STOIANOV, supra note 187, at 4.
191. Id.
192. NAT'L TELECOMM. & INFO. ADMIN., NTIA PRIVACY MULTISTAKEHOLDER PROCESS,
COMMERCIAL FACIAL RECOGNITION TECHNOLOGY, PROPOSED PRINCIPLES THAT MIGHT BE
INCORPORATED INTO A CODE OF CONDUCT (May 16, 2014), http://www.ntia.doc.gov/files/ntia/public-
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Facial Recognition.93  This provided factual findings that pointed to the
privacy concerns involved in facial recognition programs, such as the potential
for future use of the technology, individual identification, and the possibility of
exploitation of teenagers.1 94 The ACLU's recommendations included the need
to protect "biometric information from exploitation and misuse" and advocated
for government intervention and statutory legal protection.195
The next Part analyzes health-related regulations to determine whether
these regulations protect individuals from privacy breaches that may occur in
the use of FRT for medical and health purposes.
V. ANALYSIS OF FRT FOR MEDICAL PURPOSES UNDER HIPAA, GINA, AND
THE ADA
A. GINA and FRT For Medical Purposes
GINA was enacted in 2008 with the intent to protect individuals from
genetic discrimination, which is defined as the misuse of genetic information.' 6
ations/stakeholderprinciples_5_16_2014.pdf (including individual control, transparency, respect for
context, security, access and accuracy, focused collection, and accountability).
193. ACLU, AN ETHICAL FRAMEWORK FOR FACIAL RECOGNITION 1 (2014),
https://www.ntia.doc.gov/files/ntia/publications/acluanethical_frameworkforfacerecognition.pdf.
194. Id. at 1-2.
195. Id. at 2. Additionally, the Interactive Advertising Bureau has made similar observations regard-
ing the need to carefully protect biometric information and develop a code of conduct that "protects
businesses and consumers while allowing for continued innovation." INTERACTIVE ADVERT. BUREAU,
LAB PRINCIPLES FOR THE NTIA MULTISTAKEHOLDER PROCESS ON FACIAL RECOGNITION TECHNOLOGY
(2014), https://www.ntia.doc.gov/files/ntia/publications/iab-facial recognitiongoverning_principles 5.
15.pdf. (advocating for a harm-based approach, technology neutrality, security, and a public information
exception). The NTIA's June 2014 meeting included recommendations made by the International Bio-
metrics Industry Association (IBIA). INT'L BIOMETRICS INDUS. ASS'N, IBIA PRIVACY BEST PRACTICE
RECOMMENDATIONS FOR COMMERCIAL BIOMETRIC USE (2014), https://www.ntia.doc.gov/files/ntial
publications/ibiastatementtontia_-_bestpracticerecommendations_6-17-2014.pdf. Transparency
and data protection are the IBIA's "fundamental privacy tenets." Id. at 1. The IBIA acknowledged two
hurdles to crafting best practices recommendations: first, the biometric industry lacks legal authority to
impose rules on users of the technology; second, "the variety and numerous existing uses, as well as
potential uses [of FRT]" makes creating specific and narrowly tailored recommendations at best imprac-
tical. Id. The IBIA did advocate for general guidelines that could provide a framework to ease imple-
mentation of greater privacy controls in specific contexts, however. Id. at 2.
196. Genetic Information Nondiscrimination Act of 2008, Pub. L. No. 110-223, 122 Stat. 881 (codi-
fied as amended in scattered sections of 29 U.S.C. and 42 U.S.C.). See generally GENETIC INFO.
NONDISCRIMINATION ACT, http://www.ginahelp.org/ (last visited Mar. 12, 2016) (providing additional
information about the individual protections and importance of the GINA).
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GINA involves protection of "family health history, the results of genetic tests,
the use of genetic counseling and other genetic services, and participation in
genetic research." 197 Title I of GINA addresses the use of genetic information
in the issuance of health insurance, and Title II addresses prohibition of the use
of genetic information and confidentiality requirements in employment. 1'
Title I is regulated and enforced by the Department of Labor, the Centers
for Medicare and Medicaid Services, and the Department of the Treasury, and
it prohibits health insurance companies from asking for, requiring, or using
genetic information in assessing eligibility, premiums, coverage, family history,
and more.'9 9 Therefore, it is illegal for a health insurer to use a genetic test
result or family health history as a reason to deny coverage, or decide how
much someone pays. 200  Title I further prohibits insurance companies from
participating in any discriminatory actions, even if the genetic information was
inadvertently collected.20 '
Title II, regulated by the EEOC, makes it illegal for employers to use
genetic information for hiring or firing purposes, promotions, salary
computations, and employment privileges.2 02 As all discriminatory practice is
prohibited in employment, Title II further bars an employer from requesting,
demanding, or purchasing genetic information about a current employee or
their family members. 203 Therefore, "it is against the law for your employer to
use family health history and genetic test results in making decisions about
197. Genetic Information, GENETIC INFO. NONDISCRIMINATION ACT (June 2010), http://ginahelp.org/
GINAhelp.pdf.
198. Genetic Information, U.S. DEP'T HEALTH & HuM. SERVICES, http://www.hhs.gov/hipaa/for-
professionals/special-topics/genetic-information/index.html (last visited Mar. 12, 2016) ("Title I of
GINA prohibits discrimination based on genetic information in health coverage. Title II of GINA pro-
hibits discrimination based on genetic information in employment."); see also Background Information
for EEOC Notice of Proposed Rulemaking on Title II of the Genetic Information Nondiscrimination Act
of2008, U.S. EQUAL EMP. OPPORTUNITY COMMISSION (May 12, 2009), http://www.eeoc.gov/policy/
docs/qandageneticinfo.html.
199. GENETIC INFO. NONDISCRIMINATION ACT, supra note 196 (GINA & Health Insurance section);
see also id. (GINA & Employment section, How Will GINA Be Enforced subsection).
200. Id. (GINA & Health Insurance section).
201. Id.; see also id. (GINA & Health Insurance section; GINA & My Genetic Services subsection).
202. Id. (GINA & Employment section); see Genetic Information Nondiscrimination Act of 2008
(GINA) § 203, 42 U.S.C. § 2000ff-1 (2012).
203. GENETIC INFO. NONDISCRIMINATION ACT, supra note 196 (GINA & Employment section)
("There are a few exceptions to when an employer can legally have your genetic information. If an em-
ployer does have the genetic information of an employee, the employer must keep it confidential and in
a separate medical file.").
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your employment." 204 Although GINA does protect against the use of genetic
information for some purposes, it does not protect against their use for life,
disability, or long-term care insurance.205
B. GINA Applied to FRT
Although the purpose of GINA is to protect how genetic information is
used, the definitions do not seem to apply to FRT used for genetic information.
GINA's definition of genetic information encompasses the genetic tests of an
individual or his family members and the receipt of genetic services while
participating in clinical research.2 06 However, genetic information under GINA
does not include a person's age or sex, and genetic tests do not include certain
analyses completed by a healthcare professional that could reasonably lead to
detection of a disease.207 Under this definition, GINA does not cover FRT as a
means of differential diagnosis of genetic conditions. The researchers studying
FRT for genetic information are only able to provide likely conditions-not a
certain diagnosis .2 0  Therefore, this information would not be protected under
GINA. Because the software just narrows down a possibility and is not
necessarily revealing genetic information, GINA does not clearly apply to such
technology. The FRT research on genetic diseases could lead to a loophole in
GINA. After all, GINA prohibits employers from requiring or requesting an
individual to undergo genetic testing or disclosing the results of a genetic test as
a condition of employment.209 However, it does not prevent an employer from
using a photograph of the job candidate to scan through FRT to see the
likelihood of a genetic ailment. Therefore, this use must be restricted
specifically, either in GINA itself or in the Consumer Privacy Bill of Rights, as
discussed in the final Part of this Article.
204. Id.
205. Mark A. Rothstein, Currents in Contemporary Ethics: GINA, the ADA, and Genetic Discrimina-
tion in Employment, 36 J.L. MED. & ETHICS 837, 837 (2008).
206. Id.; 42 U.S.C. § 2000ff(3)-(4).
207. See Rothstein, supra note 205, at 838-39 (noting that under GINA, a genetic test "does not in-
clude ... an analysis of proteins or metabolites that is directly related to a manifested disease, disorder,
or pathological condition that could reasonably be detected by a health care professional with appropri-
ate training and expertise in the field of medicine involved"); see also 42 U.S.C. § 2000ff(7) (defining a
genetic test as "an analysis of human DNA, RNA, chromosomes, proteins, or metabolites, that detects
genotypes, mutations, or chromosomal changes").
208. See supra note 17 and accompanying text.
209. 42 U.S.C. § 2000ff-1(b).
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C HIPAA and FRT For Medical Purposes
HIPAA, in conjunction with its Privacy Rule, "establishes national
standards to protect individuals' medical records and other personal health
information and applies to health plans, health care clearinghouses, and those
health care providers that conduct certain health care transactions
electronically." 2 10 Further, in requiring privacy protection for personal health
information, it sets limits on the use of the information without individual
patient consent and affords rights to patients, such as obtaining copies of their
personal health records.21 1  HIPAA includes Administrative Simplification
provisions, which requires the HHS to implement "national standards for
electronic health care transactions and code sets, unique health identifiers, and
security." 212  Further, with advances in technology, Congress recognized the
need to incorporate provisions that applied federal privacy protection to
personally identifiable health information.213 The HHS furthered the standards
governing HIPAA in 2013 with the omnibus rule by expanding the
requirements of the HIPAA Privacy and Security Rules to include business
associates, such as subcontractors, of the entities that receive protected health
information.2 14 The Privacy, Security, and Patient Safety Rules of HIPAA are
210. The HIPAA Privacy Rule, U.S. DEP'T HEALTH & HUM. SERVICES, http://www.hhs.gov/ocr/pri-
vacy/hipaa/administrative/privacyrule/ (last visited Mar. 12, 2016); see also Health Insurance Portability
and Accountability Act of 1996 (HIPAA), 42 U.S.C. § 1320d.
This Article does not address the tort issues that FRT for medical or genetic purposes may bring
up. The Restatement (Second) of Torts, which has been adopted by a majority of states, enumerates four
separate causes of action in the privacy context: (1) intrusion; (2) public disclosure of private facts; (3)
false light in the public eye; and (4) appropriation. Shaw, supra note 10, at 152-59 (discussing the enu-
merated privacy torts). An applicable tort that may arise in the FRT context is public disclosure of pri-
vate facts. This cause of action is defined by the Restatement as "[o]ne who gives publicity to a matter
concerning the private life of another is subject to liability to the other for invasion of his privacy, if the
matter publicized is of a kind that (a) would be highly offensive to a reasonable person, and (b) is not of
legitimate concern to the public." RESTATEMENT (SECOND) OF TORTS § 652D (AM. LAW INST. 1979).
Thus, "[this] tort protects people from having facts, even though they are true, published if a reasonable
person would be offended at having such intimacies revealed." Shaw, supra note 10, at 154.
211. 45 C.F.R. §§ 164.500-.534 (2015).
212. HIPAA for Professionals, U.S. DEP'T HEALTH & HUM. SERVICES, http://www.hhs.gov/hipaa/for-
professionals/index.html (last visited Mar. 12, 2016); see also 45 C.F.R. § 162.1000 (code sets); id. §
162.406 (identifiers); id. § 162.910 (transactions); id. § 164.306 (security).
213. See generally 45 C.F.R. §§ 164.500-.534.
214. New Rule Protects Patient Privacy, Secures Health Information, U.S. DEP'T HEALTH & HUM.
SERVICES (Jan. 17, 2013) [hereinafter New Rule Protects Patient Privacy], http://www.hhs.gov/news/
press/2013pres/01/20130117b.html.
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enforced by the Office of Civil Rights. 2 15 The final omnibus rule "marks the
most sweeping changes to the HIPAA Privacy and Security Rules since they
were first implemented," according to HHS Office for Civil Rights Director
Leon Rodriguez. 216  "These changes not only greatly enhance a patient's
privacy rights and protections, but also strengthen the ability ... to vigorously
enforce the HIPAA privacy and security protections, regardless of whether the
information is being held by a health plan, a health care provider, or one of
their business associates."2 17
D. HIPAA Applied to FRT
Although there is no direct literature from HHS that states that HIPAA
applies to facial recognition technology in conjunction with genetic testing,
there are sources that seem to suggest that this is the case. According to an
article published in the Journal of Digital Imaging: "Individually identified
information, according to [HIPAA], includes 'full-face photographic images
and any comparable images.',, 218 A full-facial photograph or equivalent
photograph is protected health information (PHI),2 19 so a covered entity (most
healthcare providers, all health plans, and all healthcare clearinghouses) and
business associates would have to comply with the HIPAA use and disclosure
requirements when using or disclosing it.2 20
If someone voluntarily provides a photograph to an employer as part of a
job application, HIPAA does not apply until it gets in the hands of a covered
entity or business associate. 22 1 Then, HIPAA is triggered and regulates the
usage of the photograph. Employment laws, such as ADA and GINA, would
regulate this scenario while it is in the hands of the employer.
215. Health Information Privacy, U.S. DEP'T HEALTH & HUM. SERVICES, http://www.hhs.gov/ocr/
privacy/ (last visited Mar. 17, 2016).
216. New Rule Protects Patient Privacy, supra note 214.
217. Id.
218. Jan C. Mazura, Krishna Juluru, Joseph J. Chen, Tara A. Morgan, Majnu John & Eliot L. Siegel,
Facial Recognition Software Success Rates for the Identification of 3D Surface Reconstructed Facial
Images: Implications for Patient Privacy and Security, 25 J. DIGITAL IMAGING 347 (2012),
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348980/. The authors posit that "[i]t remains to be de-
termined whether soft tissue reconstructions of the face have sufficient detail to identify the person to
whom such an image belongs." Id.
219. 45 C.F.R. § 160.103 (2015).
220. Id. §§ 164.500-.514.
221. Id. § 164.402.
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Also, the language employed in the omnibus rule released in 2013 seems to
suggest that genetic information obtained through a facial recognition process
would be covered-HIPAA applies to electronic personal health information,
and the rule stresses the necessity for privacy maintenance. Additionally, a few
companies using FRT in conjunction with genetic testing claim to be HIPAA
compliant, thus suggesting that HIPAA should apply to this industry.2 22 For
example, FDNA 2 23 alleges compliance with standards set forth through HIPAA
and its regulatory agencies by implementation of "the appropriate Security Rule
safeguards as part of a corporate commitment to protecting personal data
through a strong security and compliance management program." 2 24  The
website individually addresses the security standards set forth and its
compliance with each, further demonstrating how HIPAA could be applied to
regulate the FRT industry.2 25
One does have a privacy interest in their face, especially if her facial
features will be used to see how long she may live or whether she is likely to
have a genetic condition.226 As suggested by the NTIA meetings, a facial
template is individually identifiable information.2 27 However, if patient consent
is obtained or if the personal health information is removed, the medical
information would not be covered under HIPAA. Although this information
may technically be individually identifiable information, there is no
requirement in HIPAA that employers cannot ask for consent to use a facial
image of a job applicant or employee. Therefore, although HIPAA may protect
the information itself, it does nothing to restrict the use of such information.
E. TheFDCAandFRT
This section considers how the FDA may regulate facial recognition
software. In addition to its traditional role of regulating food and medicines,
222. See, e.g., FDNA, http://www.fdna.com (last visited Mar. 17, 2016).
223. HIPAA Compliance Declaration, FDNA, http://www.fdna.com/hipaa-compliance-declaration/
(last updated Apr. 3, 2014). The FDNA website references Face2Gene, "a genetic search and reference
mobile application, powered by the Facial Dysmorphology Novel Analysis technology. Face2Gene fa-
cilitates detection of facial dysmorphic features and recognizable patterns of human malformations,
while referencing comprehensive and up-to-date genetic information." Id.
224. Id.
225. Id.
226. See CTR. FOR DEMOCRACY & TECH., supra note 169.
227. See supra Part llI.F.
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the FDA has also regulated medical devices since 193 8.228 More and more, the
FDA has sought jurisdiction over computerized medical technology and
devices.229
Although technology has expanded to a degree where even mobile phones
can now be converted into portable medical devices, scholars such as Nathan
Cortez argue that the FDA continues to apply an "old regulatory framework to
[these] novel products."23 0 Cortez describes the current approach of the FDA as
overseeing only mobile applications that are medical devices "whose
functionality could pose a risk to patient safety if the mobile app were to not
function as intended."2 3' Cortez critiques this discretionary approach due to the
considerably hazy distinction that this draws between products that must be
regulated and those that do not.232 Cortez argues that although the FDA does
have jurisdiction to regulate most mobile health technology, the agency may
not be equipped to respond to new applications.233
The FDA regulates medical "devices" under the federal FDCA.234 These
devices are defined broadly to include "any product intended to diagnose, cure,
mitigate, treat, or prevent disease, or any product intended to affect the
structure or function of the body." 235  "'Intended use' is a key element in
228. Regulating Cosmetics, Devices, and Veterinary Medicine After 1938, U.S. FOOD & DRUG
ADMIN., http://www.fda.gov/AboutFDA/WhatWeDo/History/Origin/ucm055137.htm (last updated Dec.
16, 2014); see also Nathan Cortez, Analog Agency in a Digital World (Working Paper 2014), (on file
with author).
229. See, e.g., Ann K. Schooley, Allowing FDA Regulation of Communications Software Used in Tel-
emedicine: A Potentially Fatal Misdiagnosis?, 50 FED. COMM. L.J. 731, 743-47 (1998); see also Cortez,
supra note 228.
230. Cortez, supra note 228, at 1.
231. Nathan G. Cortez, I. Glenn Cohen & Aaron S. Kesselheim, FDA Regulation of Mobile Health
Technologies, 4 NEW ENG. J. MED. 371, 374 (2014) (citing FOOD & DRUG ADMIN., MOBILE MEDICAL
APPLICATIONS: GUIDANCE FOR INDUSTRY AND FOOD AND DRUG ADMINISTRATION STAFF 7-8 (2013),
http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/U
CM263366.pdf) ("The FDA cites several examples, including apps that perform electrocardiography or
electroencephalography, apps that measure eye movements to diagnose balance disorders, apps that act
as wireless remote controls for computed tomography, and apps that control implantable neuromuscular
stimulators. The FDA calls these 'mobile medical applications."').
232. Cortez et al., supra note 231, at 374.
233. Nathan Cortez, The Mobile Health Revolution?, 47 U.C. DAVIS L. REv. 1173, 1200 (2014). Cor-
tez notes, specifically, that "FDA classifications are not nearly as fluid as software products .... Like
many new technologies, medical apps can complicate existing regulatory frameworks." Id. at 1201.
234. 21 U.S.C. §§ 301-99f (2012).
235. Cortez, supra note 233, at 1200-01; see also 21 U.S.C. § 321(h) (defining device as "an instru-
ment, apparatus, implement, machine ... which is ... intended for use in diagnosis ... or in the cure,
mitigation, treatment, or prevention of disease ... or intended to affect the structure or any function of
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defining 'devices,' and thus in defining the outer bounds of FDA
jurisdiction." 2 3 6  The agency, by regulation, has defined intended use as the
objective intent of how those responsible for marketing the product intend it to
be used.237 The agency can determine objective intent by looking at the product
itself, at the manufacturer's claims about it, and at other oral and written
statements by those marketing it. 238  Moreover, the FDA can consider the
"circumstances surrounding distribution of the article," including widespread
consumer use.2 39 The FDCA's broad definition of "device" enables the FDA to
exercise jurisdiction over computer hardware and software devices. 24 0  Thus,
software that intends to perform one of these broad medical functions falls
under FDA jurisdiction. 2 4' Because FDA jurisdiction depends mostly on the
way a product functions, the regulated products are wide-ranging and depend
upon the presented risks.24 2 There are three tiers denoting the authority of the
FDA to exercise jurisdiction: (1) "mobile medical apps," which fall within the
FDA category of "device" and thus within the jurisdiction of the FDA; (2)
applications that fall within the definition of "device" but not within the
definition of "mobile medical apps" for which the FDA has discretionary
enforcement; and (3) the health applications that do not meet the definition of
device and therefore do not fall within FDA jurisdiction.2 43 The second
the body").
236. Cortez, supra note 233, at 1201.
237. 21 C.F.R. § 801.4 (2015) ("The words intended uses ... refer to the objective intent of the per-
sons legally responsible for the labeling of devices. The intent is determined by such persons' expres-
sions or may be shown by labeling claims, advertising matter, or oral or written statements by such per-
sons or their representatives.").
238. Id.
239. Id.
240. 21 U.S.C. § 321(h); see also Cortez, supra note 233, at 1201-02. The Act defines a "device" as
any "instrument, apparatus, implement, machine, contrivance," or similar product "intended for use in
the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of dis-
ease," or any such product "intended to affect the structure or any function of the body." 21 U.S.C. §
321(h). This includes "any component, part or accessory." Id.
241. 21 C.F.R. § 801.4. Note, however, that FDA officials testified to Congress that the agency will
not rely on actual use to determine "intended use." See Letter from Michele Mital, Acting Associate
Commissioner for Legislation, Dep't of Health & Human Servs., to Hon. Tim Murphy, Chairman, Sub-
committee on Oversight and Investigations, Comm. on Energy and Commerce, House of Representa-
tives 2 (Mar. 20, 2013), http:// www.genomicslawreport.com/wp-content/uploads/2013/03/HousemHea-
IthLetter.pdf.
242. Cortez, supra note 233, at 1201 (discussing the three classification tiers and noting that "[t]he
higher the classification, the more scrutiny the device receives").
243. BAKUL PATEL, U.S. FOOD & DRUG ADMIN., PUBLIC WORKSHOP-MOBILE MEDICAL APPS
DRAFT GUIDANCE 8, 16 (Sept. 12, 2011), http:// www.fda.gov/downloads/MedicalDevices/NewsEvents/
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category, wherein the agency exercises discretionary authority, represents the
gray area of regulation-compliance for such products may not be required, but
is recommended.2 44
The FDA maintains the practice of addressing the regulation of mobile
medical apps as they are created.2 45 Although the overall approach by the FDA
to software is unclear, jurisdiction by the FDA has been exercised on a case-by-
case basis.4 6 The FDA has created numerous categories encompassing existing
products, and many mobile apps may fall within these established
classifications.24 7 However, the FDA may have to create entirely new
categories for the products that do not fit easily within the pre-existing
categories.248 Furthermore, although there are benefits to the case-by-case
consideration by the FDA, this approach can be piecemeal and inconsistent if
not buttressed with broadly applicable regulations.2 49 One concern about the
potential FDA regulation of "mobile medical apps" is that many medical
applications do not adhere to established medical guidelines. 25 0  Further,
software can be "user-unfriendly" or a user can be vulnerable to "automation
WorkshopsConferences/UCM271893.pdf; see also U.S. FOOD & DRUG ADMIN., MOBILE MEDICAL
APPLICATIONS: GUIDANCE FOR INDUSTRY AND FOOD AND DRUG ADMINISTRATION STAFF 8, 13 (Feb. 9,
2015), http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocu-
ments/UCM263366.pdf.
244. Cortez, supra note 233, at 1205 ("[T]he FDA says it will regulate apps that obviously are medi-
cal devices; . . . it will not regulate apps that obviously are not; and . .. it will defer on the provocative
middle tier of apps . . . ."). It is ftu-ther suggested that "the FDA must be explicit that its guidance doc-
uments are not legally binding." Id. at 1206.
245. Id. at 1209.
246. Id. at 1221.
247. Nathan Cortez, Regulating Disruptive Innovation, 29 BERKELEY TECH. L.J. 175, 193 (2014).
This includes: "medical calculators, cameras, lights, magnifiers, microscopes, monitors, recorders, re-
minders, scales, surgical tools, transmitters, and a host of data systems that store, display, and manipu-
late information." Id. at 193 n.96.
248. Cortez, supra note 233, at 1221-22 ("But many [devices] will fit uneasily, or not at all. And in
such cases, the FDA might have to create entirely new categories .. . .").
249. Cortez, supra note 247, at 193 ("The agency did pre-clear discrete software products on a case-
by-case basis, which could serve as precedent for similar products. But this piecemeal approach fell far
short of establishing a definitive, cohesive philosophy towards software that companies could use to
predict their regulatory obligations.").
250. Cortez, supra note 233, at 1193 (providing as an example a case study of smoking cessation
apps, very few of which conformed to "the evidence-based clinical practice guidelines for smoking ces-
sation programs"); accord Rochelle Sharpe, Lacking Regulation, Many Medical Apps Questionable at
Best, NEW ENG. CTR. FOR INVESTIGATIVE REPORTING (Nov. 18, 2012), http://necir.org/2012/11/18/med-
ical-apps/ (noting that few health and wellness apps "follow established medical guidelines, and few
have been tested through ... clinical research").
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bias." 251' Additionally, the "piecemeal and sporadic" regulation by the FDA is
potentially problematic because of both the case-by-case review by the agency
and reliance on non-binding guidance.252 Many scholars believe that the FDA
still lacks the resources to adequately regulate the influx of software devices
and that "as software devices become more ubiquitous and critical to patient
care, the FDA's regulatory framework remains inert." 253 An example of the
influx of software is mobile health applications. As of March 2013, there were
approximately 97,000 different applications, hundreds to thousands that qualify
,,254as medical "devices. Another worry is that the software industry is not
prepared to comply with the "technical FDA requirements," and the FDA
consistently applies a "least burdensome" approach to software regulation.25 5
F. FRTand the FDA
Mobile health applications used on smartphones and tablets may function
as medical devices, allowing for "customized diagnoses and treatment
recommendations by comparing user-specific data to vast bodies of clinical
research and accumulated medical knowledge."25 6 Similarly, FRT is based on
systems and computer programs that analyze images for identification
purposes.2 57 As previously discussed, FRT is being used for a myriad of
purposes, including predicting lifespans.258 Furthermore, there are upwards of
17,000 genetic disorders that have been diagnosed, of which about 700 can be
diagnosed with the assistance of abnormal facial characteristic recognition.25 9
Currently, FRT correctly predicts a genetic disorder, on average, 93% of the
time.26 0 It is important to protect "biometric information from exploitation and
misuse," and government intervention and statutory legal protection may be
helpful with this. 2 6' The FDA may be an appropriate platform to initiate such
251. Cortez, supra note 228, at 5. Automation bias refers to "the belief that automated computer pro-
cesses are infallible or simply less prone to make errors than they actually are." Id.
252. Id. at 6.
253. Id. at 7.
254. Id. at 10.
255. Id. at 12.
256. Cortez, supra note 233, at 1177.
257. Q&A on Face-Recognition, supra note 6.
258. Klimas, supra note 85.
259. Clark, supra note 15.
260. Weller, supra note 1.
261. NAT'L TELECOMM. & INFO. ADMIN., AN ETHICAL FRAMEWORK FOR FACIAL RECOGNITION 2,
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regulation, intervention, and legal protection. Within the FDA's case-by-case
approach under the second tier of its analysis, FRT would fall under
discretionary approval by the FDA as its uses can be classified as "devices"
within the applicable analysis. This may not be the ideal platform because the
current uses of FRT in the medical context do not necessarily fall within
"mobile medical applications." As FRT software develops more in the medical
context, the FDA may be a logical step in the regulation of this technology.
However, as currently structured, there is not clear protection of consumers and
patients via the FDCA.
G. ADA and FRTfor Medical Purposes
Another law that may help protect patients and employees from
discrimination based on FRT software is the ADA, which prohibits
discrimination on the basis of disability. 26 2  The ADA's definition of "an
individual with a disability" is one whose "physical or mental impairment that
substantially limits one or more major life activities of such individual; a record
of such an impairment; or being regarded as having such an impairment." 2 63
Prior to the ADA Amendments Act of 2008 (ADAAA), the EEOC had issued a
non-binding interpretation in 1995 stating that individuals who are
discriminated against on the basis of "genetic information relating to illness,
disease, or other disorders," are protected by the ADA.264  However, the
ADAAA superceded this guidance and did not seem to clarify if the ADA
would cover the position of the EEOC.
Under the ADA, a disability is defined as "a physical or mental impairment
that substantially limits one or more major life activities of such individual; a
record of such an impairment; or being regarded as having such an
impairment." 2 65  The ADA does not specifically list all of the various
disabilities that are covered under the Act.266 However, the broad definition
contained within the ADA expressly excludes only "transitory and minor"
https://www.ntia.doc.gov/files/ntia/publications/aclu-an-ethical_frameworkforfacerecognition.pdf
(last visited Mar. 17, 2016).
262. 42 U.S.C. § 12101(b) (2012).
263. Id. § 12102(1)-(3).
264. EEOC Compliance Manual, vol. 2, EEOC Order 915.002, 902-45.
265. 42 U.S.C. § 12102(1); accord A Guide to Disability Rights Laws, U.S. DEP'T JUST. (July 2009),
http://www.ada.gov/cguide.htm.
266. A Guide to Disability Rights Laws, supra note 265.
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267
impairments.267 Therefore, the statute likely protects hidden disabilities, or
"impairment[s] causing limitations not obvious to the naked eye, not easily
discerned by others, or not noticeable in the person's speech, behavior, or
mobility." including impairments that may have an effect on the "brain,
circulation, respiration, muscular or skeletal system, sensory abilities, etc." 2 68
There are several stereotypes associated with hidden disabilities, including
that "hidden disabilities are not believable, [they are] not as severe as obvious
disabilities like mobility impairments, [they] are hard to accommodate because
the need is not obvious, and people with hidden disabilities do not need
accommodations." 26 9 Thus, disclosure of a hidden disability in the workplace
can be a difficult decision for an employee to make. 270 ,If yOu announce your
condition, you risk being stigmatized; if you keep it a secret, you risk poor
performance reviews or even being fired." 271 Therefore, benefits of
nondisclosure-including maintenance of privacy and confidentiality in the
workplace, as well as avoiding stigmatization-could be said to outweigh those
of disclosure.2 72
H ADA Applied to FRT
It is unlikely that an unexpressed genetic condition or likelihood would rise
to the definition of disability. Also, a short predicted lifespan would also not be
deemed a disability under the ADA. Those with a potential genetic
predisposition to future illness are likely not covered by the ADA.
267. 42 U.S.C. § 12102(3).
268. SUZANNE R. GOZDEN, U.S. DEP'T LABOR, To DISCLOSE OR NOT TO DISCLOSE 5,
http://accessibilityonline.s3.amazonaws.com/archives/2004-06-15%5EDisclosure.pdf (last visited Mar.
17, 2016). This category would include impairments that may have an effect on the "brain, circulation,
respiration, muscular or skeletal systems, sensory abilities, etc." Id. Listed examples include: epilepsy,
ADD, sleep disorders, migraines, fibromyalgia, depression, PTSD, learning disabilities, HIV/AIDS,
cancer, diabetes, heart conditions, respiratory impairments, vision loss, and hearing loss. Id. Contra
Lawrence D. Rosenthal, Can't Stomach the Americans with Disabilities Act? How the Federal Courts
Have Gutted Disability Discrimination Legislation in Cases Involving Individuals with Gastrointestinal
Disorders and Other Hidden Illnesses, 53 CATH. U. L. REv. 449, 449 (2004) ("[I]t has become clear that
many people who have 'hidden' illnesses are not benefitting [from the ADA].").
269. GOZDEN, supra note 268, at 6.




272. GOZDEN, supra note 268, at 7-8.
1058
[Vol. 43: 1017, 2016] Balancing Privacy with Innovation
PEPPERDINE LAW REVIEW
VI. RECOMMENDATIONS: PROPOSED RESTRICTIONS ON THE USE OF FRT FOR
MEDICAL AND HEALTH PURPOSES
The analysis in Part IV of this Article makes clear that the health privacy,
genetic, FDA, and disability laws in the country do not protect the use of FRT
by employers or insurers for their own discriminatory purposes. There is
currently no federally applicable law that specifically addresses FRT, although
some states have passed legislation attempting to address the issues. 273  The
lack of legislation raises concerns including the possibility of privacy
violations, freedom of speech restraints, and stalking.2 74 Although the
American population acquiesces to governmental monitoring for security
purposes, people still expect a certain amount of privacy in their daily lives.275
Both the "government and the private sector have the capacity for surveillance
of nearly everyone in America., 276 There is no current constitutional basis to
prevent this, and no constitutional text that "plac[es] boundaries on the
government's ability to engage in ubiquitous monitoring of citizens based on
images snapped in public or posted online."27 7 Therefore, there is no
constitutional control covering corporations and individuals for generating the
databases of personal information, and there is no cap on governmental power
in obtaining it. 2 7 8
Another concern noted is that although this technology can be helpful in
the context of criminal law and the use by law enforcement, it "can also
perpetuate racial and ethnic profiling, social stigma, and inaccuracies
throughout all systems and can allow for government tracking and surveillance
on a level not before possible." 27 9  Furthermore, "[u]sing facial recognition
technology beyond checking attendance or to maintain security could be a
273. Kirill Levashov, Note, The Rise of a New Type of Surveillance for Which the Law Wasn't Ready,
15 COLUM. Sci. & TECH. L. REv. 164, 176-77 (2013).
274. Id. at 187.
275. Brown, supra note 10, at 409 ("[P]eople also expect to go about daily life in relative obscurity-
unidentifiable to others they do not already know, do not care to know, or are not required to know-so
long as they abide by the law.").
276. Id.
277. Id. at 410 ("The Supreme Court has made clear that the Fourth Amendment does not protect
'[w]hat a person knowingly exposes to the public.' Nor does it cover information revealed to third par-
ties.").
278. Id.
279. Kathy Gurchiek, Facial Recognition Technology Raises Privacy Issues, SOC'Y FOR HUM.
RESOURCE MGMT. (Sept. 14, 2012), http://www.shrm.org/hrdisciplines/technology/articles/pages/facial-
recognition-privacy.aspx.
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slippery slope into privacy issues if its use by employers or their vendors veers
into sourcing potential job candidates." 28 0 The counter-argument is that FRT
will be so expensive to implement that it is not likely that it will be used in the
employment context. However, FRT, like any new technology, will be
cheaper as it becomes more ubiquitous.282
Restrictions are needed to prevent employers, insurers, and any other entity
or individual from using FRT for medical or health purposes without the
individual's specific consent. Furthermore, employers and insurers should be
restricted from being able to ask for this information-or for any genetic
information. Such a restriction will protect individuals from feeling coerced
into consenting. There are definite upsides to the FRT research described in
this Article. However, it is necessary to protect individuals from unwittingly
revealing medical and health information.
The most direct fix to the issue of the misuse of FRT for medical purposes
would be the enactment of a regulation interpreting GINA that makes clear that
FRT cannot be used by employers or insurers for the purpose of attempting to
determine genetic predispositions. This would be the clearest way to ensure
that GINA works as it is intended to. Including tests or software that narrows
down a possibility of genetic predispositions in the definition of genetic
information in GINA would close the loophole in GINA discussed earlier.
Additionally, the Consumer Privacy Bill of Rights may be amended to
address the medical and health potential of FRT. The July 2014 NTIA meeting
considered the Consumer Privacy Bill of Rights.283 Specifically, the
stakeholders discussed: (1) what type of entities the code provisions would
apply to; (2) obligations imposed when no "facial template" is created; (3) what
obligations are imposed when the information is not stored; (4) the risk of
individual's information being stored without consent or knowledge; (5) the
worry that a code of conduct "could preclude or hinder meritorious uses of
commercial FRT"; (6) individuals being denied product or services based on a
280. Id.
281. Id. (noting that at least some experts in the field "think[] the cost of the technology will be so
prohibitive that many employers will not use it.").
282. Matt Rosoff, Every Type of Technology Has Gotten Cheaper over the Last Two Decades-
Except for One, Bus. INSIDER (Oct. 14, 2015), http://www.businessinsider.com/historical-price-trends-
for-tech-products-2015-10 ("As technology gets more advanced, prices drop and products get better.").
283. Privacy Multistakeholder Process: Facial Recognition Technology, supra note 181; see also
NTIA Seeks Comment on Big Data and the Consumer Privacy Bill ofRights, NAT'L TELECOMM. & INFO.
ADMIN. (June 4, 2014), https://www.ntia.doc.gov/press-release/2014/ntia-seeks-comment-big-data-and-
consumer-privacy-bill-rights.
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refusal to consent to enrollment of a facial recognition template; (7) risk of
commercial use of FRT infringing on personal autonomy and erosion of
personal privacy; (8) the chilling effects on free speech and free assembly; (9)
risk of unanticipated commercial use of the technology that consumers do not
understand; and (10) the risk that FRT could result in discriminatory practices
or patterns of behavior such as predatory marketing.2 84 Each of these ten
concerns is important, but does not address what kind of regulatory mechanism
is needed for FRT for medical and health purposes. Even if a facial template is
not stored, it is necessary to have privacy protections when FRT can reveal
private health information. The Consumer Privacy Bill of Rights could be a
good way to ensure privacy, but it needs to be expanded to include issues that
are central to medical or health information, as suggested above.
FRT software is developing rapidly to address a whole host of health-
related issues. The law must catch up to this technology. The answer is not
necessarily to prevent the development of this technology-but rather to ensure
that the way it is used is consistent with the laws that protect genetic privacy.
1061
284. NAT'L TELECOMM. & INFO. ADMIN., NTIA MULTISTAKEHOLDER PROCESS ON FACIAL
RECOGNITION TECHNOLOGY 1-4 (2014), https://www.ntia.doc.gov/files/ntia/publications/ntiadraft-li-
st of issues_7_22_14.pdf.
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